data_1xx3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xx3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.568 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.444 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.6 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.52 ' HA ' ' HB1' ' A' ' 209' ' ' ALA . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 4.0 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.53 ' HD2' HD12 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 173' ' ' GLU . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.437 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.594 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.659 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.41 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.774 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.461 HD13 ' HZ1' ' A' ' 207' ' ' LYS . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.665 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.665 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.617 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.446 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.683 ' HB2' HG22 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.576 ' CG ' HD23 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.53 HD12 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.433 HD21 HG23 ' A' ' 235' ' ' THR . 9.6 t30 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.433 HG23 HD21 ' A' ' 233' ' ' ASN . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.433 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD12 ' A' ' 238' ' ' ILE . 6.3 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.588 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.423 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.829 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.569 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.586 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD21 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.602 HG22 HG12 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG21 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.784 HD22 ' H ' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.865 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.865 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.494 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.488 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.816 ' HZ1' ' HB3' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.677 ' HB2' HG22 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.513 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.513 HD12 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.438 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.569 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.829 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.438 HG21 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.509 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 160' ' ' GLN . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.426 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.436 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.426 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.702 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.492 ' CB ' ' HE3' ' A' ' 201' ' ' MET . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.702 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.424 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.54 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 11.9 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.638 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.82 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.628 HG13 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.904 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.542 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.41 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.695 ' HB2' HG22 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.638 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 3.6 t30 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.914 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.914 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.435 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 56.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 . . . . . 0 CA--C 1.514 -0.437 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.523 ' HA ' HD12 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HB2' ' HE3' ' A' ' 201' ' ' MET . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 172' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 206' ' ' VAL . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HG2' HD11 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD12 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.666 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.421 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.679 ' HB2' HG22 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.555 ' HA ' HG21 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 172' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.458 ' HB2' HD12 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.542 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.712 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.516 HD13 ' HG2' ' A' ' 203' ' ' GLU . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.635 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.617 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.516 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.749 HG12 HG22 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.621 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.67 ' HB2' HG22 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.449 ' HH ' ' HZ ' ' A' ' 180' ' ' PHE . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG3' HD23 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.46 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.457 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.445 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.549 ' OE1' HD11 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.586 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 173' ' ' GLU . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 172' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.588 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.583 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.407 ' CD2' HG11 ' A' ' 188' ' ' VAL . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' CG ' ' HG1' ' A' ' 183' ' ' THR . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.519 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.52 HG12 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.954 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.606 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.583 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.623 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.623 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.727 ' HB2' HG22 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.495 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.495 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.588 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.594 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.427 HG21 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.549 HD11 ' OE1' ' A' ' 160' ' ' GLN . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.561 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.561 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 173' ' ' GLU . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 3.7 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.73 ' HB2' HD12 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.628 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.482 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.4 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.46 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.433 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.453 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.443 HD22 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.434 ' HD2' HG21 ' A' ' 228' ' ' ILE . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.517 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 7.4 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.696 HG21 HG22 ' A' ' 206' ' ' VAL . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.538 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.974 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 1.1 m-80 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.656 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.679 ' HB2' HG22 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.465 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.563 ' HB3' HE21 ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.434 HG21 ' HD2' ' A' ' 161' ' ' PRO . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.638 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.558 ' HE1' HG23 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.638 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.418 HG13 HG22 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.563 HE21 ' HB3' ' A' ' 227' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.564 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.512 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.564 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.555 ' HB2' ' HE3' ' A' ' 201' ' ' MET . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.616 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.412 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.7 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.632 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.526 ' HG2' HD11 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 206' ' ' VAL . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD12 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.607 ' HG1' ' HB2' ' A' ' 187' ' ' ARG . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.607 ' HB2' ' HG1' ' A' ' 183' ' ' THR . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.464 HD13 ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.555 ' HE3' ' HB2' ' A' ' 166' ' ' ARG . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.464 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG22 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.455 ' HD2' HD11 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.512 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.401 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.75 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.538 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.75 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.585 HG13 ' HB3' ' A' ' 170' ' ' LEU . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.695 HG21 HG22 ' A' ' 206' ' ' VAL . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 HG12 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.546 ' HZ3' ' HB2' ' A' ' 179' ' ' LYS . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.434 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.501 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.075 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.075 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 176' ' ' VAL . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.536 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.536 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.612 ' HB2' HG22 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.434 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.497 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.64 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.554 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.531 HG21 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 160' ' ' GLN . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.453 ' NE2' HD11 ' A' ' 238' ' ' ILE . 5.9 mm-40 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.749 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.433 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.0 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 173' ' ' GLU . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.537 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 12.8 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.567 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.69 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.574 ' HZ1' ' HB2' ' A' ' 179' ' ' LYS . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 221' ' ' GLY . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.481 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.48 HG13 HG21 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.588 HD11 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.525 ' CD ' ' HZ2' ' A' ' 207' ' ' LYS . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.749 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.525 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.717 ' HB2' HG22 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.679 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.679 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.498 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.567 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.537 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.632 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.423 ' HG2' HD11 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.424 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.409 HG13 ' HE2' ' A' ' 210' ' ' MET . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 178' ' ' VAL . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.423 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.715 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.477 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 207' ' ' LYS . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG22 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.438 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.541 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.829 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.829 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.501 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.551 ' HG2' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.542 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.478 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.529 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 206' ' ' VAL . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.454 ' HB2' HD12 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.447 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.566 HG13 HG21 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.451 ' HB2' HG11 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.924 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.584 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.448 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.448 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.447 ' HE3' ' CD1' ' A' ' 180' ' ' PHE . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.54 ' HB2' HG22 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.542 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.529 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.551 HD11 ' HG2' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.467 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.433 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.442 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 206' ' ' VAL . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.466 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.697 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG21 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.046 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.046 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 176' ' ' VAL . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.669 ' HB2' HG22 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.638 ' CG ' HD12 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.432 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.467 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.522 0.201 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 3.5 mm100 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.589 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.479 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.57 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.455 HG13 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.527 HG13 HG21 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.017 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.017 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.489 ' HE3' ' HG3' ' A' ' 166' ' ' ARG . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.65 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HG2' HG13 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.779 ' HB2' HG22 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.674 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.3 t30 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.57 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.414 ' HB ' ' CG ' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.477 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.477 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.489 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.549 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.528 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.487 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.665 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 179' ' ' LYS . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.65 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.65 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.464 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.608 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 200' ' ' ASN . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.449 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.665 HG12 HG22 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.665 ' HB2' HG22 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.405 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.637 ' HG3' HD23 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.617 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.487 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.425 HD21 HG23 ' A' ' 235' ' ' THR . 9.4 t30 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.425 HG23 HD21 ' A' ' 233' ' ' ASN . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 49.7 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.428 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.566 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.566 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.703 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.699 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.635 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 224' ' ' ILE . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.792 HD22 ' H ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.935 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.48 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 176' ' ' VAL . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 0.2 OUTLIER -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG22 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.589 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 217' ' ' PRO . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.589 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.423 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 180' ' ' PHE . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG21 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.703 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 233' ' ' ASN . 0.1 OUTLIER -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.621 HG21 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.945 0.402 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.7 HD12 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.509 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.406 HD22 ' HB2' ' A' ' 212' ' ' ARG . 8.4 p30 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.701 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.701 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.549 HG23 ' HE1' ' A' ' 230' ' ' PHE . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HB2' HD12 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.428 HG13 HG21 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.006 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.006 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.875 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.423 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.406 ' HB2' HD22 ' A' ' 159' ' ' ASN . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.704 ' HB2' HG22 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.7 ' HG3' HD12 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.421 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.549 ' HE1' HG23 ' A' ' 176' ' ' VAL . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.414 HE21 HD22 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 173' ' ' GLU . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.416 ' HG2' HD11 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.025 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.025 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.617 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG22 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.701 ' HB ' HG23 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.698 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.704 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.698 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.409 HG13 HG12 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.928 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.508 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.504 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.534 HG21 HG22 ' A' ' 206' ' ' VAL . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.665 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 HG12 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 1.073 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 1.073 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.476 ' N ' ' HZ2' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.562 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.943 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . 0.693 ' HB2' HG22 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.432 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 217' ' ' PRO . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 160' ' ' GLN . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.87 -151.03 21.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.606 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 215' ' ' TYR . 15.5 Cg_endo -59.83 125.45 17.76 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 123.117 2.545 . . . . 0.0 111.776 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.568 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 -90.45 142.97 27.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.767 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.444 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.6 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.52 ' HA ' ' HB1' ' A' ' 209' ' ' ALA . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 4.0 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.53 ' HD2' HD12 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 173' ' ' GLU . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.437 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.594 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.659 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.41 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.774 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.461 HD13 ' HZ1' ' A' ' 207' ' ' LYS . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.665 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.665 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.617 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.446 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.683 ' HB2' HG22 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.507 ' HD2' ' HB2' ' A' ' 153' ' ' PRO . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.576 ' CG ' HD23 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.53 HD12 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.433 HD21 HG23 ' A' ' 235' ' ' THR . 9.6 t30 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.433 HG23 HD21 ' A' ' 233' ' ' ASN . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 -158.42 26.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.543 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.51 118.15 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.726 2.284 . . . . 0.0 111.732 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.433 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 -102.11 136.4 42.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD12 ' A' ' 238' ' ' ILE . 6.3 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.588 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.423 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.829 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.569 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.586 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD21 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.602 HG22 HG12 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG21 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.784 HD22 ' H ' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.865 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.865 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.494 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.488 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.816 ' HZ1' ' HB3' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.677 ' HB2' HG22 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.513 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.513 HD12 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.438 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.569 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.829 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.438 HG21 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.509 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 160' ' ' GLN . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.22 173.76 48.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.548 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.48 113.86 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.655 2.237 . . . . 0.0 111.499 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -84.32 126.39 33.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.426 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.436 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.426 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.702 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.492 ' CB ' ' HE3' ' A' ' 201' ' ' MET . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.702 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.424 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.54 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 11.9 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.638 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.82 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.628 HG13 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.904 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.542 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.41 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.695 ' HB2' HG22 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.638 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 3.6 t30 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.914 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.914 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.435 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 56.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA2' ' HE2' ' A' ' 219' ' ' LYS . . . 82.74 -168.3 47.37 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.12 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.98 119.77 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.314 2.009 . . . . 0.0 112.114 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -95.7 134.5 38.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.954 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.523 ' HA ' HD12 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HB2' ' HE3' ' A' ' 201' ' ' MET . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 172' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 206' ' ' VAL . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HG2' HD11 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD12 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.666 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.421 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.679 ' HB2' HG22 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.42 ' HE2' ' HA2' ' A' ' 152' ' ' GLY . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.555 ' HA ' HG21 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.42 168.69 22.83 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.85 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.92 109.21 1.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 110.959 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -91.97 135.27 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 172' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.458 ' HB2' HD12 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.542 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.712 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.516 HD13 ' HG2' ' A' ' 203' ' ' GLU . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.635 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.617 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.516 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.749 HG12 HG22 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.621 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.67 ' HB2' HG22 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.449 ' HH ' ' HZ ' ' A' ' 180' ' ' PHE . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG3' HD23 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.46 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.457 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.445 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 160' ' ' GLN . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.972 0.415 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.15 -177.53 53.33 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.501 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.37 117.37 4.07 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.503 2.136 . . . . 0.0 110.932 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.01 136.21 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.549 ' OE1' HD11 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.586 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 173' ' ' GLU . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 172' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.588 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.583 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.407 ' CD2' HG11 ' A' ' 188' ' ' VAL . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' CG ' ' HG1' ' A' ' 183' ' ' THR . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.519 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.52 HG12 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.954 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.606 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.583 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.623 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.623 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.727 ' HB2' HG22 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.495 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.495 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.588 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.594 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.427 HG21 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.549 HD11 ' OE1' ' A' ' 160' ' ' GLN . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.974 0.416 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.08 -179.76 25.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.442 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.474 ' HB2' ' CD2' ' A' ' 215' ' ' TYR . 36.6 Cg_endo -72.02 119.22 6.04 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 111.966 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.058 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.561 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.561 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 173' ' ' GLU . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 3.7 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.73 ' HB2' HD12 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.628 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.482 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.4 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.46 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 153' ' ' PRO . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.433 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.453 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 100.98 153.0 26.22 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.874 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.91 143.68 9.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.127 2.551 . . . . 0.0 112.746 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -84.63 137.43 33.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.443 HD22 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.434 ' HD2' HG21 ' A' ' 228' ' ' ILE . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.517 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 7.4 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.696 HG21 HG22 ' A' ' 206' ' ' VAL . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.538 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.974 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 1.1 m-80 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.656 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.679 ' HB2' HG22 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.465 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.563 ' HB3' HE21 ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.434 HG21 ' HD2' ' A' ' 161' ' ' PRO . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.638 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.558 ' HE1' HG23 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.638 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.418 HG13 HG22 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.563 HE21 ' HB3' ' A' ' 227' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.63 -176.46 21.51 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.8 100.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.287 1.991 . . . . 0.0 110.678 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -106.99 127.98 53.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.992 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.564 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.512 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.564 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.555 ' HB2' ' HE3' ' A' ' 201' ' ' MET . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.616 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.412 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.7 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.632 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.526 ' HG2' HD11 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 206' ' ' VAL . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD12 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.607 ' HG1' ' HB2' ' A' ' 187' ' ' ARG . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.607 ' HB2' ' HG1' ' A' ' 183' ' ' THR . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.464 HD13 ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.555 ' HE3' ' HB2' ' A' ' 166' ' ' ARG . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.464 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG22 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' HD2' HD11 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.512 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.401 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.75 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.538 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.75 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.53 -167.31 38.79 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.349 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.93 101.18 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.647 2.231 . . . . 0.0 110.749 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.81 132.31 42.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.888 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.585 HG13 ' HB3' ' A' ' 170' ' ' LEU . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.695 HG21 HG22 ' A' ' 206' ' ' VAL . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 HG12 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.546 ' HZ3' ' HB2' ' A' ' 179' ' ' LYS . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.434 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.501 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.075 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.075 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 176' ' ' VAL . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.536 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.536 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.612 ' HB2' HG22 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.434 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.497 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.64 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.554 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.531 HG21 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 160' ' ' GLN . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.117 0.484 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.99 -164.28 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.149 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.827 ' HB3' ' HE2' ' A' ' 215' ' ' TYR . 91.5 Cg_exo -45.24 144.36 4.39 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.594 2.863 . . . . 0.0 113.844 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -138.72 126.4 22.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.572 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.453 ' NE2' HD11 ' A' ' 238' ' ' ILE . 5.9 mm-40 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.749 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.433 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.0 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 173' ' ' GLU . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.537 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 12.8 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.567 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.69 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.574 ' HZ1' ' HB2' ' A' ' 179' ' ' LYS . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 221' ' ' GLY . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.481 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.48 HG13 HG21 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.588 HD11 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.525 ' CD ' ' HZ2' ' A' ' 207' ' ' LYS . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.749 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.525 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.717 ' HB2' HG22 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.827 ' HE2' ' HB3' ' A' ' 153' ' ' PRO . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.679 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.498 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.567 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.537 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.914 0.388 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.58 168.14 33.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.071 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.501 ' HG2' ' CD2' ' A' ' 215' ' ' TYR . 93.6 Cg_endo -90.44 167.58 4.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.134 2.556 . . . . 0.0 112.063 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -96.99 137.49 36.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.632 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.423 ' HG2' HD11 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.424 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.409 HG13 ' HE2' ' A' ' 210' ' ' MET . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 178' ' ' VAL . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.423 HD11 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.715 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.477 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 207' ' ' LYS . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG22 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.501 ' CD2' ' HG2' ' A' ' 153' ' ' PRO . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.541 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.829 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.829 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.2 54.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.34 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.53 ' HB2' ' HE2' ' A' ' 215' ' ' TYR . 38.0 Cg_endo -74.94 143.87 29.8 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.533 1.488 . . . . 0.0 111.167 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.501 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 -133.33 116.82 16.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.551 ' HG2' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.542 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.478 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.529 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 206' ' ' VAL . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.454 ' HB2' HD12 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.447 ' CD1' ' HE3' ' A' ' 210' ' ' MET . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.566 HG13 HG21 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' HB2' HG11 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.924 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.584 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.448 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.448 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.447 ' HE3' ' CD1' ' A' ' 180' ' ' PHE . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.54 ' HB2' HG22 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.53 ' HE2' ' HB2' ' A' ' 153' ' ' PRO . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.542 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.529 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.551 HD11 ' HG2' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.66 -169.05 17.8 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.866 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 215' ' ' TYR . 55.6 Cg_endo -70.75 145.79 52.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.661 2.241 . . . . 0.0 111.906 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -97.35 145.37 26.2 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.467 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.433 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.442 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 206' ' ' VAL . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.466 ' HG2' HD11 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.697 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG21 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.046 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.046 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 176' ' ' VAL . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.669 ' HB2' HG22 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 153' ' ' PRO . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.638 ' CG ' HD12 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.432 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.467 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.25 -169.71 54.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.221 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.51 120.22 7.33 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.316 2.01 . . . . 0.0 111.589 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -83.35 139.34 33.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 3.5 mm100 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.589 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.479 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.57 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.455 HG13 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.527 HG13 HG21 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.017 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.017 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.489 ' HE3' ' HG3' ' A' ' 166' ' ' ARG . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.65 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HG2' HG13 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.779 ' HB2' HG22 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.674 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.3 t30 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.57 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.414 ' HB ' ' CG ' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.047 0.451 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.7 177.15 35.39 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.01 139.79 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.937 2.425 . . . . 0.0 111.727 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -92.8 135.94 33.68 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.477 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.477 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.489 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.549 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.528 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.487 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.665 HG22 HG12 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' HZ3' ' HB2' ' A' ' 179' ' ' LYS . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.65 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.65 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.464 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.608 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 200' ' ' ASN . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.449 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.665 HG12 HG22 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.665 ' HB2' HG22 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.405 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.637 ' HG3' HD23 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 176' ' ' VAL . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.617 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.487 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.425 HD21 HG23 ' A' ' 235' ' ' THR . 9.4 t30 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.425 HG23 HD21 ' A' ' 233' ' ' ASN . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 49.7 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.601 0.239 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.91 -174.95 53.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.051 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.637 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 28.2 Cg_endo -69.98 149.75 65.91 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.279 1.986 . . . . 0.0 111.814 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 -137.42 121.52 17.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.428 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.566 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.566 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.703 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.699 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.635 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 224' ' ' ILE . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.792 HD22 ' H ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.935 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.48 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 176' ' ' VAL . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 0.2 OUTLIER -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG22 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 153' ' ' PRO . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 217' ' ' PRO . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.589 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.423 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 180' ' ' PHE . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG21 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.703 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 233' ' ' ASN . 0.1 OUTLIER -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.621 HG21 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.23 47.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.235 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.39 104.49 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.882 2.388 . . . . 0.0 111.846 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -99.06 130.69 45.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.7 HD12 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.509 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.406 HD22 ' HB2' ' A' ' 212' ' ' ARG . 8.4 p30 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.701 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.701 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.549 HG23 ' HE1' ' A' ' 230' ' ' PHE . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HB2' HD12 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.428 HG13 HG21 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.006 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.006 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.875 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.423 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.406 ' HB2' HD22 ' A' ' 159' ' ' ASN . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.704 ' HB2' HG22 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.7 ' HG3' HD12 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.421 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.549 ' HE1' HG23 ' A' ' 176' ' ' VAL . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.414 HE21 HD22 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.506 0.193 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.05 174.73 31.78 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.227 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.447 ' HG3' HG23 ' A' ' 182' ' ' VAL . 74.0 Cg_endo -79.15 146.39 19.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.887 2.391 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER -98.78 161.95 13.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.29 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 172' ' ' ILE . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 173' ' ' GLU . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.416 ' HG2' HD11 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.025 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.025 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.617 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG22 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.701 ' HB ' HG23 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.698 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.704 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.698 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.409 HG13 HG12 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.676 0.275 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.75 -174.4 51.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.961 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.41 132.7 52.39 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.731 2.288 . . . . 0.0 111.483 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.928 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -88.12 132.02 34.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 -176.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.508 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.504 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.534 HG21 HG22 ' A' ' 206' ' ' VAL . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.665 ' HB2' ' HZ1' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 HG12 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 1.073 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 1.073 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.476 ' N ' ' HZ2' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.562 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.943 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . 0.693 ' HB2' HG22 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.432 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 217' ' ' PRO . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' HG23 ' A' ' 176' ' ' VAL . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 160' ' ' GLN . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.601 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.0 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HG2' HD13 ' A' ' 228' ' ' ILE . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.639 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HD2' HD11 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 198' ' ' PRO . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.64 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 191' ' ' VAL . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 210' ' ' MET . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.597 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.672 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.62 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.47 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.519 ' HG3' HG11 ' A' ' 191' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG21 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.601 ' HG3' HD21 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.679 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.639 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.539 HD11 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 230' ' ' PHE . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.551 HG13 HG23 ' A' ' 228' ' ' ILE . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.445 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.642 ' HA ' HD11 ' A' ' 238' ' ' ILE . 6.8 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.585 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.853 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.52 ' HG2' HD23 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.818 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.866 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.514 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 219' ' ' LYS . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 218' ' ' GLY . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.529 ' HA3' HD11 ' A' ' 224' ' ' ILE . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.529 HD11 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 238' ' ' ILE . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.47 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.853 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 228' ' ' ILE . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.54 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.412 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 1.5 mt-30 -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.73 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.411 ' O ' HD23 ' A' ' 170' ' ' LEU . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.73 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 5.4 pp0? -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 166' ' ' ARG . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.421 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 9.0 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.652 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.632 HG22 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.922 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.567 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.707 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HA ' ' HE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.707 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.726 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.686 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 21.5 t-20 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.943 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.943 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' OH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 21.6 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 . . . . . 0 CA--C 1.514 -0.437 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.535 ' HA ' HD11 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 170' ' ' LEU . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 232' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HG2' HD12 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HB2' HD11 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.4 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.99 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.71 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.447 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.416 HG21 ' HE3' ' A' ' 177' ' ' LYS . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.587 ' HA ' HG22 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.62 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.62 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 170' ' ' LEU . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.7 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.417 ' HB3' HG22 ' A' ' 191' ' ' VAL . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.713 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.713 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 180' ' ' PHE . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.542 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.661 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.678 ' HB2' HG21 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.597 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.457 ' CD2' HG22 ' A' ' 236' ' ' THR . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.475 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 228' ' ' ILE . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 215' ' ' TYR . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 216' ' ' GLU . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.443 HG21 ' HG3' ' A' ' 198' ' ' PRO . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.522 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.725 HG11 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.606 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.725 ' HG3' HG11 ' A' ' 191' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.763 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 155' ' ' ALA . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.464 ' HG3' HD11 ' A' ' 156' ' ' LEU . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 178' ' ' VAL . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 22.9 t-20 -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.609 HD13 ' HG2' ' A' ' 161' ' ' PRO . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.603 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.474 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.436 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 228' ' ' ILE . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.572 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' HD13 ' A' ' 228' ' ' ILE . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 9.6 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.758 HG22 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.502 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.758 HG13 HG22 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.409 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.685 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.587 ' HB2' HG21 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.77 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.625 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.493 HD21 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' N ' HG22 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 48.3 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.573 HG22 ' HE1' ' A' ' 230' ' ' PHE . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 210' ' ' MET . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 11.8 m-20 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.71 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.71 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 211' ' ' ARG . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HB2' HD21 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.698 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.441 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 22.2 t-20 -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 238' ' ' ILE . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.642 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.573 ' HE1' HG22 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 91.8 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.562 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.562 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.9 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB3' HD11 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.624 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.723 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 2.9 pp0? -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 178' ' ' VAL . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.734 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.471 ' HD2' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.528 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.413 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 17.4 t-20 -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 52.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' CE1' ' A' ' 202' ' ' PHE . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 170' ' ' LEU . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.664 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.675 HG21 ' HG3' ' A' ' 198' ' ' PRO . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.463 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 228' ' ' ILE . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.653 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.079 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.079 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 162' ' ' GLN . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 210' ' ' MET . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.556 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.649 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.665 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.444 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 12.9 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 198' ' ' PRO . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.9 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.603 ' HG2' HD12 ' A' ' 194' ' ' LEU . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.601 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.466 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.735 ' HB2' HG21 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.701 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' A' ' 221' ' ' GLY . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.624 HG23 HG13 ' A' ' 238' ' ' ILE . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.554 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.646 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.646 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.413 ' CD ' HD13 ' A' ' 228' ' ' ILE . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 196' ' ' ALA . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.501 ' CG1' ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.762 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.705 ' HB2' HG21 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.453 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.858 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.507 HD13 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' HA ' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.646 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.495 ' O ' HD13 ' A' ' 170' ' ' LEU . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 5.2 pp0? -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 166' ' ' ARG . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HG2' HD12 ' A' ' 194' ' ' LEU . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 193' ' ' ILE . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.927 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.446 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.556 ' HB2' HG21 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.418 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.418 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 14.1 t-20 -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.562 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.544 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.8 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 196' ' ' ALA . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.784 HG22 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 221' ' ' GLY . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.778 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.778 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.707 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.701 HG21 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.784 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.074 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.51 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.701 ' HB2' HG21 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.64 ' CG ' HD11 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.486 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.452 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 238' ' ' ILE . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.421 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.497 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 215' ' ' TYR . 1.9 tpt180 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.522 0.201 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 14.0 mm-40 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.426 ' HG2' HD13 ' A' ' 228' ' ' ILE . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.631 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.631 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.429 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 193' ' ' ILE . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 191' ' ' VAL . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.767 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.853 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.853 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.429 HD12 ' HG2' ' A' ' 177' ' ' LYS . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.031 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.524 ' HG2' HG11 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.783 ' HB2' HG21 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' ARG . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 8.8 t-20 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.58 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.43 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 228' ' ' ILE . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD21 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.478 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.729 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.542 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 1.5 pp0? -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.663 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 191' ' ' VAL . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 180' ' ' PHE . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.656 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.965 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.965 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.609 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.469 ' HB2' ' OE1' ' A' ' 205' ' ' GLU . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.662 ' HB2' HG21 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.638 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.521 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.729 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.499 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 228' ' ' ILE . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 51.0 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' A' ' 216' ' ' GLU . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.402 ' ND2' ' HB1' ' A' ' 209' ' ' ALA . 3.9 p-10 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 160' ' ' GLN . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.574 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.454 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.725 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.426 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 180' ' ' PHE . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG22 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.936 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 14.7 t-20 -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB1' ' ND2' ' A' ' 159' ' ' ASN . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.709 ' HB2' HG21 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.607 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.475 ' CG ' HD23 ' A' ' 156' ' ' LEU . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.607 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.435 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.49 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.725 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 228' ' ' ILE . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.945 0.402 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.727 HD11 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.703 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' A' ' 196' ' ' ALA . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HB2' HD11 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.033 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.463 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.876 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.45 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.691 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.727 ' HG3' HD11 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 161' ' ' PRO . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.488 HD21 HE21 ' A' ' 239' ' ' GLN . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.571 ' HA ' HG22 ' A' ' 236' ' ' THR . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.488 HE21 HD21 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.475 ' HG2' HD13 ' A' ' 228' ' ' ILE . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.718 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.577 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 201' ' ' MET . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 167' ' ' ALA . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.732 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.837 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.837 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.561 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.028 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.708 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.718 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 230' ' ' PHE . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.954 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.577 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.516 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.459 ' HB2' ' HE2' ' A' ' 201' ' ' MET . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.479 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.444 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 194' ' ' LEU . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.505 ' HB3' HG22 ' A' ' 191' ' ' VAL . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 1.081 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 1.081 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.517 ' N ' ' HZ3' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.58 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' A' ' 193' ' ' ILE . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' TRP . . . . . 0.731 ' HB2' HG21 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.571 ' HG2' HD13 ' A' ' 156' ' ' LEU . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.699 HG23 HG13 ' A' ' 238' ' ' ILE . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.693 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.699 HG13 HG23 ' A' ' 228' ' ' ILE . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.87 -151.03 21.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.606 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 215' ' ' TYR . 15.5 Cg_endo -59.83 125.45 17.76 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 123.117 2.545 . . . . 0.0 111.776 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 -90.45 142.97 27.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.767 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.601 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.0 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HG2' HD13 ' A' ' 228' ' ' ILE . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.639 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HD2' HD11 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 198' ' ' PRO . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.64 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 191' ' ' VAL . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 210' ' ' MET . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.597 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.672 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.62 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.47 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.519 ' HG3' HG11 ' A' ' 191' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG21 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 153' ' ' PRO . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.601 ' HG3' HD21 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.679 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.639 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.539 HD11 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 230' ' ' PHE . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.551 HG13 HG23 ' A' ' 228' ' ' ILE . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 -158.42 26.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.543 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.51 118.15 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.726 2.284 . . . . 0.0 111.732 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.445 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 -102.11 136.4 42.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.642 ' HA ' HD11 ' A' ' 238' ' ' ILE . 6.8 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.585 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.853 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.52 ' HG2' HD23 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.818 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.866 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.514 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 219' ' ' LYS . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 218' ' ' GLY . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.529 ' HA3' HD11 ' A' ' 224' ' ' ILE . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.529 HD11 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 238' ' ' ILE . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.47 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.853 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 228' ' ' ILE . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.22 173.76 48.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.548 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.48 113.86 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.655 2.237 . . . . 0.0 111.499 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -84.32 126.39 33.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.54 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.412 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 1.5 mt-30 -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.73 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.411 ' O ' HD23 ' A' ' 170' ' ' LEU . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.73 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 5.4 pp0? -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 166' ' ' ARG . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.421 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 9.0 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.652 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.632 HG22 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.922 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.567 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.707 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HA ' ' HE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.707 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.726 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.686 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 21.5 t-20 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.943 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.943 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' OH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 21.6 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' HE2' ' A' ' 219' ' ' LYS . . . 82.74 -168.3 47.37 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.12 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.98 119.77 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.314 2.009 . . . . 0.0 112.114 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -95.7 134.5 38.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.954 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.535 ' HA ' HD11 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 170' ' ' LEU . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 232' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HG2' HD12 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HB2' HD11 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.4 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.99 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.71 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.447 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.449 ' HE2' ' HA2' ' A' ' 152' ' ' GLY . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.416 HG21 ' HE3' ' A' ' 177' ' ' LYS . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.587 ' HA ' HG22 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.42 168.69 22.83 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.85 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.92 109.21 1.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 110.959 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -91.97 135.27 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.62 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.62 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 170' ' ' LEU . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.7 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.417 ' HB3' HG22 ' A' ' 191' ' ' VAL . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.713 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.713 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 180' ' ' PHE . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.542 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.661 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.678 ' HB2' HG21 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.597 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.457 ' CD2' HG22 ' A' ' 236' ' ' THR . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.475 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 228' ' ' ILE . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.972 0.415 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.15 -177.53 53.33 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.501 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.37 117.37 4.07 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.503 2.136 . . . . 0.0 110.932 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.01 136.21 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 215' ' ' TYR . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 216' ' ' GLU . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.443 HG21 ' HG3' ' A' ' 198' ' ' PRO . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.522 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.725 HG11 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.606 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.725 ' HG3' HG11 ' A' ' 191' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.763 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 155' ' ' ALA . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.464 ' HG3' HD11 ' A' ' 156' ' ' LEU . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 178' ' ' VAL . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 22.9 t-20 -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.609 HD13 ' HG2' ' A' ' 161' ' ' PRO . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.603 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.474 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.436 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 228' ' ' ILE . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.974 0.416 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.08 -179.76 25.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.442 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HB2' ' CD2' ' A' ' 215' ' ' TYR . 36.6 Cg_endo -72.02 119.22 6.04 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 111.966 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.058 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.572 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' HD13 ' A' ' 228' ' ' ILE . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 9.6 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.758 HG22 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.502 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.758 HG13 HG22 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.409 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.685 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.587 ' HB2' HG21 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 153' ' ' PRO . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.77 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.625 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 100.98 153.0 26.22 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.874 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.91 143.68 9.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.127 2.551 . . . . 0.0 112.746 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -84.63 137.43 33.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.493 HD21 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' N ' HG22 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 48.3 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.573 HG22 ' HE1' ' A' ' 230' ' ' PHE . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 210' ' ' MET . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 11.8 m-20 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.71 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.71 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 211' ' ' ARG . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HB2' HD21 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.698 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.441 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 22.2 t-20 -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 238' ' ' ILE . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.642 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.573 ' HE1' HG22 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 91.8 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.63 -176.46 21.51 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.8 100.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.287 1.991 . . . . 0.0 110.678 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -106.99 127.98 53.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.992 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.562 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.562 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.9 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB3' HD11 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.624 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.723 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 2.9 pp0? -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 178' ' ' VAL . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.734 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.471 ' HD2' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.528 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.413 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 17.4 t-20 -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.53 -167.31 38.79 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.349 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.93 101.18 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.647 2.231 . . . . 0.0 110.749 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.81 132.31 42.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.888 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 52.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' CE1' ' A' ' 202' ' ' PHE . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 170' ' ' LEU . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.664 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.675 HG21 ' HG3' ' A' ' 198' ' ' PRO . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.463 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 228' ' ' ILE . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.653 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.079 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.079 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 162' ' ' GLN . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 210' ' ' MET . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.556 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.649 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.665 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.444 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.117 0.484 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.99 -164.28 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.149 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.817 ' HB3' ' HE2' ' A' ' 215' ' ' TYR . 91.5 Cg_exo -45.24 144.36 4.39 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.594 2.863 . . . . 0.0 113.844 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -138.72 126.4 22.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.572 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 12.9 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 198' ' ' PRO . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.9 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.603 ' HG2' HD12 ' A' ' 194' ' ' LEU . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.601 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.466 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.735 ' HB2' HG21 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.817 ' HE2' ' HB3' ' A' ' 153' ' ' PRO . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.701 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' A' ' 221' ' ' GLY . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.624 HG23 HG13 ' A' ' 238' ' ' ILE . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.554 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.914 0.388 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.58 168.14 33.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.071 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 215' ' ' TYR . 93.6 Cg_endo -90.44 167.58 4.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.134 2.556 . . . . 0.0 112.063 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -96.99 137.49 36.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.646 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.646 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.413 ' CD ' HD13 ' A' ' 228' ' ' ILE . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 196' ' ' ALA . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 153' ' ' PRO . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.501 ' CG1' ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.762 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.705 ' HB2' HG21 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 153' ' ' PRO . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.858 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.2 54.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.34 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.519 ' HB2' ' HE2' ' A' ' 215' ' ' TYR . 38.0 Cg_endo -74.94 143.87 29.8 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.533 1.488 . . . . 0.0 111.167 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 -133.33 116.82 16.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.507 HD13 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' HA ' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.646 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.495 ' O ' HD13 ' A' ' 170' ' ' LEU . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 5.2 pp0? -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 166' ' ' ARG . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HG2' HD12 ' A' ' 194' ' ' LEU . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 193' ' ' ILE . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.927 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.446 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.556 ' HB2' HG21 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' A' ' 153' ' ' PRO . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.418 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 14.1 t-20 -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.562 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.544 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.66 -169.05 17.8 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.866 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HB2' ' HB3' ' A' ' 215' ' ' TYR . 55.6 Cg_endo -70.75 145.79 52.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.661 2.241 . . . . 0.0 111.906 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -97.35 145.37 26.2 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 13.8 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 196' ' ' ALA . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.784 HG22 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 221' ' ' GLY . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.778 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.778 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.707 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.701 HG21 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.784 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.074 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.51 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.701 ' HB2' HG21 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 153' ' ' PRO . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.64 ' CG ' HD11 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.486 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.452 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 238' ' ' ILE . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.421 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.497 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.25 -169.71 54.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.221 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.51 120.22 7.33 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.316 2.01 . . . . 0.0 111.589 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 215' ' ' TYR . 1.9 tpt180 -83.35 139.34 33.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 14.0 mm-40 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.426 ' HG2' HD13 ' A' ' 228' ' ' ILE . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.631 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.631 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.429 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 193' ' ' ILE . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 191' ' ' VAL . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.767 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.853 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.853 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.429 HD12 ' HG2' ' A' ' 177' ' ' LYS . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.031 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.524 ' HG2' HG11 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.783 ' HB2' HG21 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' ARG . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 8.8 t-20 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.58 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.43 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 228' ' ' ILE . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.047 0.451 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.7 177.15 35.39 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.01 139.79 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.937 2.425 . . . . 0.0 111.727 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -92.8 135.94 33.68 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD21 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.478 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.729 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.542 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 1.5 pp0? -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.663 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 191' ' ' VAL . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 180' ' ' PHE . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.656 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.965 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.965 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.609 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.469 ' HB2' ' OE1' ' A' ' 205' ' ' GLU . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.662 ' HB2' HG21 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.638 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.521 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.729 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.499 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 228' ' ' ILE . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 51.0 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.601 0.239 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.91 -174.95 53.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.051 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.597 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 28.2 Cg_endo -69.98 149.75 65.91 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.279 1.986 . . . . 0.0 111.814 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 -137.42 121.52 17.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' A' ' 216' ' ' GLU . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.402 ' ND2' ' HB1' ' A' ' 209' ' ' ALA . 3.9 p-10 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 160' ' ' GLN . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.574 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.454 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.725 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.426 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 180' ' ' PHE . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG22 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.936 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 14.7 t-20 -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB1' ' ND2' ' A' ' 159' ' ' ASN . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.709 ' HB2' HG21 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.607 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.475 ' CG ' HD23 ' A' ' 156' ' ' LEU . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.607 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.435 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.49 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.725 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 228' ' ' ILE . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.23 47.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.235 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.39 104.49 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.882 2.388 . . . . 0.0 111.846 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -99.06 130.69 45.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.727 HD11 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.703 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' A' ' 196' ' ' ALA . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HB2' HD11 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.033 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.463 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.876 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.45 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.691 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.727 ' HG3' HD11 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 161' ' ' PRO . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.488 HD21 HE21 ' A' ' 239' ' ' GLN . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.571 ' HA ' HG22 ' A' ' 236' ' ' THR . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.488 HE21 HD21 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.506 0.193 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.05 174.73 31.78 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.227 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.427 ' HG3' HG21 ' A' ' 182' ' ' VAL . 74.0 Cg_endo -79.15 146.39 19.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.887 2.391 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER -98.78 161.95 13.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.29 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.475 ' HG2' HD13 ' A' ' 228' ' ' ILE . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.718 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.577 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 201' ' ' MET . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 167' ' ' ALA . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.732 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.837 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.837 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.561 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.028 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.708 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.718 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 230' ' ' PHE . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.676 0.275 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.75 -174.4 51.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.961 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.41 132.7 52.39 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.731 2.288 . . . . 0.0 111.483 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.954 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -88.12 132.02 34.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 -176.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.577 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.516 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.459 ' HB2' ' HE2' ' A' ' 201' ' ' MET . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.479 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.444 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 194' ' ' LEU . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.505 ' HB3' HG22 ' A' ' 191' ' ' VAL . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 1.081 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 1.081 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.517 ' N ' ' HZ3' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.58 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' A' ' 193' ' ' ILE . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' TRP . . . . . 0.731 ' HB2' HG21 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.571 ' HG2' HD13 ' A' ' 156' ' ' LEU . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.699 HG23 HG13 ' A' ' 238' ' ' ILE . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.693 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.699 HG13 HG23 ' A' ' 228' ' ' ILE . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.601 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HG2' HD13 ' A' ' 228' ' ' ILE . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.639 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 4.0 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HD2' HD11 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 198' ' ' PRO . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.64 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 191' ' ' VAL . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 210' ' ' MET . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.597 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.672 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.62 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.47 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.519 ' HG3' HG11 ' A' ' 191' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG21 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.601 ' HG3' HD21 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.679 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.639 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.539 HD11 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 235' ' ' THR . 9.6 t30 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 233' ' ' ASN . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 230' ' ' PHE . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.551 HG13 HG23 ' A' ' 228' ' ' ILE . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.445 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.642 ' HA ' HD11 ' A' ' 238' ' ' ILE . 6.3 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 162' ' ' GLN . 18.7 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.585 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.853 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.52 ' HG2' HD23 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.818 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.866 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.514 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 219' ' ' LYS . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 218' ' ' GLY . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.529 ' HA3' HD11 ' A' ' 224' ' ' ILE . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.529 HD11 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 238' ' ' ILE . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.47 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.853 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.508 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 228' ' ' ILE . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.54 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.412 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.73 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.411 ' O ' HD23 ' A' ' 170' ' ' LEU . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.73 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 166' ' ' ARG . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.421 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 11.9 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.652 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.632 HG22 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.922 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.567 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.707 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HA ' ' HE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.707 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.726 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.686 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 3.6 t30 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.943 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.943 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' OH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 56.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 . . . . . 0 CA--C 1.514 -0.437 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.535 ' HA ' HD11 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 170' ' ' LEU . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 232' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HG2' HD12 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HB2' HD11 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.4 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.99 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.71 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.447 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.416 HG21 ' HE3' ' A' ' 177' ' ' LYS . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.587 ' HA ' HG22 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.62 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.62 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 170' ' ' LEU . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.417 ' HB3' HG22 ' A' ' 191' ' ' VAL . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.713 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.713 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 180' ' ' PHE . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.542 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.661 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.678 ' HB2' HG21 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.597 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.457 ' CD2' HG22 ' A' ' 236' ' ' THR . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.475 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 228' ' ' ILE . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 215' ' ' TYR . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 216' ' ' GLU . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.443 HG21 ' HG3' ' A' ' 198' ' ' PRO . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.522 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.725 HG11 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.606 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.725 ' HG3' HG11 ' A' ' 191' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.763 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 155' ' ' ALA . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.464 ' HG3' HD11 ' A' ' 156' ' ' LEU . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 178' ' ' VAL . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.609 HD13 ' HG2' ' A' ' 161' ' ' PRO . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.603 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.474 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.436 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 228' ' ' ILE . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.572 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' HD13 ' A' ' 228' ' ' ILE . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 3.7 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.758 HG22 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.502 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.758 HG13 HG22 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.409 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.685 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.587 ' HB2' HG21 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.77 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.625 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.493 HD21 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' N ' HG22 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 7.4 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.573 HG22 ' HE1' ' A' ' 230' ' ' PHE . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 210' ' ' MET . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 1.1 m-80 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.71 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.71 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 211' ' ' ARG . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HB2' HD21 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.698 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.441 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.636 ' HB3' HE21 ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 238' ' ' ILE . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.642 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.573 ' HE1' HG22 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 227' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.562 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.562 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.1 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB3' HD11 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.624 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.723 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 178' ' ' VAL . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.734 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.471 ' HD2' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.528 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.413 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 7.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' CE1' ' A' ' 202' ' ' PHE . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 170' ' ' LEU . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.664 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.675 HG21 ' HG3' ' A' ' 198' ' ' PRO . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.463 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 228' ' ' ILE . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.653 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.079 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.079 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 162' ' ' GLN . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 210' ' ' MET . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.556 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.649 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.665 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.444 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.473 ' NE2' HD12 ' A' ' 238' ' ' ILE . 5.9 mm-40 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.0 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 198' ' ' PRO . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 12.8 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.603 ' HG2' HD12 ' A' ' 194' ' ' LEU . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.601 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.466 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.735 ' HB2' HG21 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.701 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' A' ' 221' ' ' GLY . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.624 HG23 HG13 ' A' ' 238' ' ' ILE . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.554 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.646 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.646 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.413 ' CD ' HD13 ' A' ' 228' ' ' ILE . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 196' ' ' ALA . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.501 ' CG1' ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.762 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.705 ' HB2' HG21 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.453 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.858 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.507 HD13 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' HA ' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.646 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.495 ' O ' HD13 ' A' ' 170' ' ' LEU . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 166' ' ' ARG . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HG2' HD12 ' A' ' 194' ' ' LEU . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 193' ' ' ILE . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.927 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.446 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.556 ' HB2' HG21 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.418 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.418 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.562 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.544 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 196' ' ' ALA . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.784 HG22 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 221' ' ' GLY . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.778 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.778 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.707 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.701 HG21 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.784 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.074 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.51 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.701 ' HB2' HG21 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.64 ' CG ' HD11 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.486 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.452 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 238' ' ' ILE . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.421 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.497 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 215' ' ' TYR . 1.9 tpt180 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.522 0.201 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 3.5 mm100 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.426 ' HG2' HD13 ' A' ' 228' ' ' ILE . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.631 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.631 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.429 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 193' ' ' ILE . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 191' ' ' VAL . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.767 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.853 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.853 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.429 HD12 ' HG2' ' A' ' 177' ' ' LYS . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.031 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.524 ' HG2' HG11 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.783 ' HB2' HG21 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' ARG . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.3 t30 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.58 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.43 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 228' ' ' ILE . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD21 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.478 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.729 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.542 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.663 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 191' ' ' VAL . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 180' ' ' PHE . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.656 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.965 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.965 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.609 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.469 ' HB2' ' OE1' ' A' ' 205' ' ' GLU . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.662 ' HB2' HG21 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.638 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.521 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.729 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.499 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.459 HD22 HG23 ' A' ' 235' ' ' THR . 9.4 t30 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.459 HG23 HD22 ' A' ' 233' ' ' ASN . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 228' ' ' ILE . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 49.7 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' A' ' 216' ' ' GLU . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 212' ' ' ARG . 8.0 p30 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 160' ' ' GLN . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.574 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.454 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.725 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.426 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 180' ' ' PHE . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG22 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.936 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 0.2 OUTLIER -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.709 ' HB2' HG21 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.607 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.475 ' CG ' HD23 ' A' ' 156' ' ' LEU . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.607 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.435 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.492 ' N ' HD22 ' A' ' 227' ' ' ASN . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.725 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.425 HD22 ' H ' ' A' ' 233' ' ' ASN . 0.1 OUTLIER -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 228' ' ' ILE . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.945 0.402 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.727 HD11 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 212' ' ' ARG . 8.4 p30 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.703 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' A' ' 196' ' ' ALA . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HB2' HD11 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.033 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.463 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.876 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.45 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.691 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 159' ' ' ASN . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.727 ' HG3' HD11 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 161' ' ' PRO . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.488 HD21 HE21 ' A' ' 239' ' ' GLN . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.571 ' HA ' HG22 ' A' ' 236' ' ' THR . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.488 HE21 HD21 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.475 ' HG2' HD13 ' A' ' 228' ' ' ILE . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.718 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.577 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 201' ' ' MET . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 167' ' ' ALA . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.732 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.837 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.837 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.561 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.028 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.708 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.718 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 230' ' ' PHE . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.954 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.577 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.516 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.459 ' HB2' ' HE2' ' A' ' 201' ' ' MET . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.479 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.444 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 194' ' ' LEU . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.505 ' HB3' HG22 ' A' ' 191' ' ' VAL . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 1.081 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 1.081 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.517 ' N ' ' HZ3' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.58 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' A' ' 193' ' ' ILE . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . 0.731 ' HB2' HG21 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.571 ' HG2' HD13 ' A' ' 156' ' ' LEU . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.699 HG23 HG13 ' A' ' 238' ' ' ILE . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.693 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.699 HG13 HG23 ' A' ' 228' ' ' ILE . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.87 -151.03 21.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.606 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 215' ' ' TYR . 15.5 Cg_endo -59.83 125.45 17.76 Favored 'Trans proline' 0 C--N 1.327 -0.569 0 C-N-CA 123.117 2.545 . . . . 0.0 111.776 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' OE2' ' A' ' 216' ' ' GLU . 39.7 ttt-85 -90.45 142.97 27.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.767 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.53 124.39 37.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.508 0.67 . . . . 0.0 111.616 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.601 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.5 mm? -95.46 -47.78 6.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.851 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 36.3 t -120.99 80.37 1.63 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.128 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -85.9 60.43 6.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.74 130.5 43.2 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.79 0.805 . . . . 0.0 111.556 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -71.5 131.3 86.51 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.042 -176.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HG2' HD13 ' A' ' 228' ' ' ILE . 27.6 Cg_exo -60.64 154.49 54.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.294 1.996 . . . . 0.0 110.911 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.96 138.96 31.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.462 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.639 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 3.1 t80 -66.81 145.44 98.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.21 130.41 3.45 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.114 3.209 . . . . 0.0 112.245 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 168' ' ' GLN . . . -71.51 -18.45 62.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.358 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 201' ' ' MET . 36.0 ttm180 -80.45 -42.1 23.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 174.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.66 -32.02 63.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.416 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 165' ' ' ALA . 4.0 pt20 -64.51 -35.83 82.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.299 0.571 . . . . 0.0 110.348 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.9 -12.88 60.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.0 mm? -103.36 -2.26 27.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.078 175.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HD2' HD11 ' A' ' 232' ' ' ILE . 21.2 mmt180 56.94 35.02 25.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.967 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 198' ' ' PRO . 48.0 mt -85.56 153.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.992 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.3 mt-10 -118.55 132.03 56.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -105.3 116.88 5.38 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.742 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.64 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 4.1 pt20 -111.24 103.1 11.47 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.7 m -105.91 136.6 39.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.376 0.607 . . . . 0.0 111.182 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.0 ttmm -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -118.97 140.97 41.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.7 ttpt -117.46 140.66 49.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.045 0.45 . . . . 0.0 109.823 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 191' ' ' VAL . 32.1 p90 -140.13 173.57 11.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.003 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.95 160.51 33.39 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -132.28 149.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 11.2 p -84.16 176.82 3.4 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.737 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 11.7 Cg_exo -64.14 -8.22 15.8 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.937 2.424 . . . . 0.0 111.687 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 19.7 t70 -95.99 -4.92 42.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.421 . . . . 0.0 110.024 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.44 32.92 32.97 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.34 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 61.1 mtt180 -102.59 128.1 49.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.653 0.263 . . . . 0.0 110.844 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -72.54 128.08 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.474 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.46 169.19 22.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.452 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.7 34.63 14.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 111.191 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 210' ' ' MET . 95.7 t -76.86 117.09 21.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.951 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.71 127.44 38.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.281 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.89 112.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.597 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -75.62 -39.58 57.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.111 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.6 m -159.19 152.72 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.491 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.45 164.16 36.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.672 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 38.6 mmtt -61.45 -74.23 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 15.9 Cg_endo -97.88 124.9 0.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.277 1.318 . . . . 0.0 112.189 163.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -44.01 -83.34 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.871 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -2.62 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.652 -170.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.62 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 78.8 mmm -73.52 -35.84 65.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.0 m-85 -110.9 -29.93 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.47 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 5.8 mt-10 -47.99 -42.78 28.81 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.29 -46.05 89.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.549 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -27.23 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.583 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 178' ' ' VAL . 55.7 t -62.97 -53.85 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.99 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 64.1 mttp -53.99 -40.17 66.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.195 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -59.32 -39.23 82.45 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.442 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.06 -44.48 60.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.304 0.573 . . . . 0.0 111.095 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.519 ' HG3' HG11 ' A' ' 191' ' ' VAL . 87.3 mmm -59.86 -25.66 65.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.321 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 83.1 mtp180 -73.41 -12.75 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -111.46 -9.59 14.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.676 ' HB2' HG21 ' A' ' 188' ' ' VAL . 18.0 m0 -56.0 131.24 46.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 125.41 48.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.453 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 153' ' ' PRO . 24.7 m-85 -116.35 143.34 45.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.102 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.601 ' HG3' HD21 ' A' ' 156' ' ' LEU . 76.7 mt-10 -52.59 120.12 17.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.86 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.0 Cg_endo -60.8 156.67 41.96 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.166 2.578 . . . . 0.0 112.246 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.12 62.72 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.597 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -135.91 114.73 11.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.89 150.76 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.772 2.315 . . . . 0.0 111.568 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -134.61 143.45 15.13 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.9 m -136.03 120.87 18.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.747 0.308 . . . . 0.0 110.903 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.25 52.59 3.73 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.08 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.62 109.6 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.9 132.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 111.127 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 11.5 m -129.52 171.41 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.46 125.41 36.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.679 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -105.12 123.48 59.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.059 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 239' ' ' GLN . 2.3 mm? -100.3 101.41 12.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.282 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.639 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 86.3 m-85 -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 8.4 mmpt? -85.66 149.81 25.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.323 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.539 HD11 ' HD2' ' A' ' 171' ' ' ARG . 14.9 tt -53.98 -28.86 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.733 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 235' ' ' THR . 9.6 t30 -70.53 -10.45 59.27 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.341 0.591 . . . . 0.0 110.905 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 96.6 26.87 10.27 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 233' ' ' ASN . 81.1 p -106.01 165.12 11.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 230' ' ' PHE . 29.7 p -140.89 139.5 34.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.038 -170.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -147.96 145.19 28.47 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.551 HG13 HG23 ' A' ' 228' ' ' ILE . 2.6 mp -120.51 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.247 -0.283 . . . . 0.0 110.718 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 229' ' ' LEU . 63.3 mt-30 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.373 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 -158.42 26.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.543 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.51 118.15 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.726 2.284 . . . . 0.0 111.732 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.445 ' HB3' ' OE1' ' A' ' 216' ' ' GLU . 36.5 ttp180 -102.11 136.4 42.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 114.03 20.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.755 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -73.46 -30.21 63.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.866 172.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 30.6 t -144.42 85.0 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.05 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -94.9 65.43 2.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.47 129.49 39.93 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.16 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.642 ' HA ' HD11 ' A' ' 238' ' ' ILE . 6.3 mt-30 -73.76 128.33 87.0 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.896 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 230' ' ' PHE . 17.9 Cg_exo -60.66 149.95 84.72 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 111.524 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 162' ' ' GLN . 18.7 mt-30 -85.35 153.82 22.29 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.265 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 164' ' ' PRO . 24.8 t80 -80.46 145.31 58.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.223 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.585 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 11.9 Cg_endo -87.44 138.7 4.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.538 3.492 . . . . 0.0 112.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.8 69.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.943 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -74.04 -41.32 61.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.385 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.05 65.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.899 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' CE2' ' A' ' 163' ' ' TYR . 15.6 mm-40 -60.25 -43.5 96.08 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.459 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.92 -15.73 61.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.177 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 170' ' ' LEU . 3.2 mm? -100.9 -4.64 27.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.141 0.496 . . . . 0.0 110.8 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.2 mmt180 55.11 51.57 13.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.008 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 173' ' ' GLU . 25.1 mt -98.85 163.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.853 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 20.1 mt-10 -123.11 106.63 10.95 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.86 99.75 1.54 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.229 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.6 mt-30 -99.4 102.52 14.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -106.93 139.97 26.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.327 0.584 . . . . 0.0 111.248 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.52 ' HG2' HD23 ' A' ' 194' ' ' LEU . 8.1 ttpm? -114.59 117.28 30.45 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 206' ' ' VAL . 2.4 t -122.88 141.95 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.138 -174.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 34.1 ttmt -118.47 130.63 56.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -140.54 173.18 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.751 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -125.51 157.23 37.54 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -126.15 146.48 31.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.3 p -80.86 161.71 62.56 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.516 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 35.1 Cg_endo -64.54 -3.82 7.21 Favored 'Trans proline' 0 C--O 1.221 -0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.479 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.54 -15.24 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.076 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 106.08 45.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.571 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 mmm180 -125.35 147.04 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.9 t -90.22 125.24 43.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.869 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -150.34 171.91 16.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.42 36.59 20.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.474 0.654 . . . . 0.0 110.572 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -78.94 119.76 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.485 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.99 125.26 34.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.947 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -84.0 113.49 22.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.729 0.776 . . . . 0.0 109.416 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.818 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -78.06 -35.9 48.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.893 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.3 m -163.48 159.62 22.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.854 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.1 177.02 11.77 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.866 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 0.5 OUTLIER -63.81 -54.6 40.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.363 172.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.4 Cg_endo -92.08 -151.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.441 2.094 . . . . 0.0 110.145 164.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.04 -94.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.887 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.66 -8.53 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 84.1 mmm -58.07 -34.6 70.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.203 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 206' ' ' VAL . 14.5 m-85 -111.57 -29.12 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.514 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 24.9 mt-10 -48.09 -34.1 9.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -53.15 -62.05 1.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.986 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -79.3 -20.16 48.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.972 -170.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 202' ' ' PHE . 52.1 t -64.58 -58.48 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 9.1 mtpm? -63.28 -33.45 75.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.309 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.93 -38.54 91.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.013 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.34 -33.85 55.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.882 0.372 . . . . 0.0 110.629 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 91.4 mtp -65.86 -23.49 66.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 0.0 111.101 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -68.74 -20.14 64.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.423 . . . . 0.0 110.562 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -97.75 -9.02 27.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.583 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 39.3 m0 -64.13 110.07 2.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.63 0.729 . . . . 0.0 110.712 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.4 OUTLIER -106.62 129.85 54.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.856 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -116.94 158.26 24.35 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.606 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 154' ' ' ARG . 38.4 mt-10 -59.32 135.72 88.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.636 0.585 . . . . 0.0 111.3 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 56.8 Cg_endo -80.62 137.78 11.66 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.824 2.349 . . . . 0.0 112.174 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 219' ' ' LYS . . . 109.49 -6.88 31.91 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 218' ' ' GLY . 14.1 mptt -127.67 112.74 20.77 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -89.71 153.2 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.965 2.443 . . . . 0.0 111.867 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.529 ' HA3' HD11 ' A' ' 224' ' ' ILE . . . -132.06 153.91 20.75 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.8 m -143.32 127.08 17.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.198 0.499 . . . . 0.0 111.434 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.77 42.45 61.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.39 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.529 HD11 ' HA3' ' A' ' 221' ' ' GLY . 2.7 mt -90.3 118.12 34.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.81 134.19 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.271 0.557 . . . . 0.0 111.345 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.94 161.03 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.911 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.75 116.55 21.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.241 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 238' ' ' ILE . 6.0 mt -104.48 116.75 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.773 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.47 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -94.64 98.89 11.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.496 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 77.1 m-85 -88.59 88.12 7.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.7 mmpt? -65.73 153.88 40.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.909 0.385 . . . . 0.0 110.752 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.853 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.0 tt -61.72 -18.2 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.966 -170.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.3 -23.94 62.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.061 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.85 22.3 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.28 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.5 p -104.15 167.59 9.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.675 -0.309 . . . . 0.0 110.291 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 230' ' ' PHE . 64.8 p -143.2 157.69 44.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.362 -166.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.508 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 41.4 tt0 -165.31 136.89 4.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.219 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 228' ' ' ILE . 3.6 mp -103.0 137.05 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.048 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.473 176.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.22 173.76 48.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.548 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.48 113.86 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.655 2.237 . . . . 0.0 111.499 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -84.32 126.39 33.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -78.18 107.73 10.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.221 0.534 . . . . 0.0 111.896 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.54 HD13 ' HG2' ' A' ' 216' ' ' GLU . 4.9 tp -74.29 -38.66 63.32 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 214' ' ' ARG . 34.0 t -116.58 -81.16 0.61 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.918 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.412 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 70.1 mtt180 56.09 60.63 3.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 110.228 -168.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.51 143.34 44.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.368 0.604 . . . . 0.0 110.048 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -84.7 131.11 50.57 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.074 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 160' ' ' GLN . 23.2 Cg_exo -60.47 155.22 48.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.727 2.284 . . . . 0.0 111.736 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 205' ' ' GLU . 53.7 tt0 -80.97 134.98 35.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.415 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.73 ' HE2' ' HB3' ' A' ' 168' ' ' GLN . 9.0 t80 -71.15 148.12 93.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 34.4 Cg_endo -98.16 124.69 0.18 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 125.124 3.883 . . . . 0.0 112.568 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 168' ' ' GLN . . . -66.89 -21.83 65.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.411 ' O ' HD23 ' A' ' 170' ' ' LEU . 99.0 mtt180 -62.5 -46.37 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.749 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.47 76.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.385 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.73 ' HB3' ' HE2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -66.99 -34.99 78.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.665 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.36 -21.6 61.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.508 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 166' ' ' ARG . 2.9 mm? -92.62 1.49 57.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.553 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 61.22 39.76 15.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.528 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 173' ' ' GLU . 11.3 mt -108.67 157.68 8.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.489 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 0.3 OUTLIER -132.69 138.58 47.33 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 166.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.421 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.06 119.83 5.67 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.923 -173.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 11.9 pt20 -107.93 108.02 18.98 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.652 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -101.06 137.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.364 0.602 . . . . 0.0 110.693 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -112.66 105.68 13.91 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.632 HG22 HG13 ' A' ' 193' ' ' ILE . 2.9 t -117.47 141.39 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.951 0.405 . . . . 0.0 111.984 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 37.7 tttm -110.55 136.99 48.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -141.42 165.28 27.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.217 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -134.4 122.18 22.18 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.95 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.651 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 26.5 p -84.47 167.85 24.69 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.372 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.07 2.25 1.49 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.859 2.373 . . . . 0.0 111.956 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.43 -8.13 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.311 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.82 32.9 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.658 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.9 OUTLIER -102.48 129.09 48.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 111.475 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 213' ' ' TRP . 23.9 t -81.45 127.1 39.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.224 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -150.94 177.42 10.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 63.03 27.83 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.427 0.632 . . . . 0.0 110.549 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.5 t -75.16 120.17 24.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.467 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -139.2 124.24 18.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.252 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -78.54 113.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.751 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.64 -35.27 58.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.136 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.1 m -157.83 148.84 21.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.05 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.44 152.6 30.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.922 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 78.0 tttt -67.1 -62.81 3.3 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.149 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.1 Cg_endo -83.86 -179.55 4.16 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.512 1.475 . . . . 0.0 110.082 161.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -97.04 -92.93 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.742 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -80.3 -1.02 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.307 . . . . 0.0 111.006 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.567 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 90.7 mmm -64.6 -39.99 94.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.541 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 206' ' ' VAL . 41.8 m-85 -110.54 -35.4 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 7.0 mt-10 -48.24 -37.86 17.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 204' ' ' ARG . 43.7 ttp-105 -59.56 -46.26 89.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.994 -174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 162' ' ' GLN . 1.4 mm-40 -81.42 -29.06 34.01 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.979 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.707 ' O ' ' HG2' ' A' ' 210' ' ' MET . 52.3 t -60.73 -55.71 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.001 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -58.64 -34.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.409 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.72 -36.7 83.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.499 ' HA ' ' HE ' ' A' ' 212' ' ' ARG . . . -69.29 -38.56 78.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.707 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.8 mmm -59.98 -32.9 71.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -73.24 -14.93 61.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.566 0.698 . . . . 0.0 110.605 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' A' ' 209' ' ' ALA . 77.9 mtm180 -100.18 -11.39 20.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.045 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.726 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.5 m0 -67.61 109.66 3.37 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.528 0.68 . . . . 0.0 111.615 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 157' ' ' SER . 11.7 mmt180 -96.49 124.29 40.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.837 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -112.26 152.98 27.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.099 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.54 ' HG2' HD13 ' A' ' 156' ' ' LEU . 29.5 mt-10 -56.07 116.37 12.27 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 123.555 0.534 . . . . 0.0 110.799 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.7 144.95 97.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.574 2.183 . . . . 0.0 111.399 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.5 -6.87 33.96 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.702 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.19 110.44 10.72 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.58 152.15 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.927 2.418 . . . . 0.0 111.187 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -141.6 132.24 5.18 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.588 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.5 m -112.11 127.3 55.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.686 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 68.55 56.21 10.34 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.356 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.99 109.2 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.98 122.49 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.736 0.779 . . . . 0.0 110.775 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.62 175.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.898 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 3.6 t30 -137.87 123.66 19.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.729 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 176' ' ' VAL . 12.8 mt -102.46 120.27 51.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.167 0.508 . . . . 0.0 110.637 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.943 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.6 mm? -94.8 98.81 11.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.227 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 94.4 m-85 -90.36 94.98 9.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.943 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 20.6 mmtp -71.3 146.88 48.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' OH ' ' A' ' 163' ' ' TYR . 15.4 tt -60.39 -20.35 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.195 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.18 -8.93 59.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.12 -12.62 24.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.853 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.0 p -84.18 169.34 14.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.529 0.664 . . . . 0.0 110.884 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.1 p -135.19 155.18 51.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.555 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 229' ' ' LEU . 35.2 tt0 -149.48 150.91 33.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.22 132.57 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.16 0.505 . . . . 0.0 111.391 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 56.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.026 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' HE2' ' A' ' 219' ' ' LYS . . . 82.74 -168.3 47.37 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.12 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.98 119.77 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.314 2.009 . . . . 0.0 112.114 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -95.7 134.5 38.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.954 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.43 18.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.888 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.92 -37.39 81.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 40.1 t -138.25 96.62 3.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -103.27 52.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 171.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -55.92 132.79 50.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.339 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.535 ' HA ' HD11 ' A' ' 238' ' ' ILE . 32.9 mt-30 -77.32 129.77 76.72 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.784 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 23.8 Cg_exo -60.43 158.9 29.46 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.343 2.696 . . . . 0.0 112.594 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -82.18 130.83 35.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.884 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 27.7 p90 -83.17 138.56 42.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.7 Cg_endo -86.73 133.85 3.74 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.32 2.68 . . . . 0.0 112.273 -171.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.42 66.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 170' ' ' LEU . 20.4 mtm180 -65.89 -37.97 87.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.407 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.4 59.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.69 -33.96 71.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.61 -23.16 62.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 109.669 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.3 mp -91.42 1.25 57.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.624 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.86 37.67 18.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.369 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 173' ' ' GLU . 24.3 mt -99.82 159.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.285 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 232' ' ' ILE . 22.5 pt-20 -137.43 128.61 27.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.82 152.13 23.66 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.657 -168.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.97 104.44 4.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -107.94 135.8 45.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.55 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HG2' HD12 ' A' ' 194' ' ' LEU . 85.9 tttt -112.92 109.34 18.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -116.41 146.86 20.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.376 -171.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HB2' HD11 ' A' ' 194' ' ' LEU . 37.8 ttmt -115.54 134.68 54.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.967 170.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.4 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.0 p90 -142.37 175.2 9.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.473 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 0.6 OUTLIER -138.99 149.88 45.2 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.3 m -118.97 147.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 20.1 p -82.79 168.69 21.38 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.643 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 20.9 Cg_endo -61.38 -12.29 23.28 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.604 2.203 . . . . 0.0 112.35 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 6.9 p-10 -107.01 5.57 28.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.857 0.36 . . . . 0.0 110.755 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.38 45.02 6.69 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.667 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 24.3 mmt180 -111.12 129.58 55.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.282 . . . . 0.0 110.412 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.6 t -82.13 125.47 39.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.637 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.72 169.45 19.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.326 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.03 38.61 24.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.564 0.697 . . . . 0.0 110.731 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.4 t -77.16 111.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.835 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.714 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -71.01 116.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.329 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 179' ' ' LYS . 14.5 mt -79.41 -37.5 37.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.9 m -157.77 152.94 25.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.892 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.87 178.98 9.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.99 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 37.3 ttmt -83.91 -68.04 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 3.0 Cg_endo -90.41 164.73 4.44 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.659 1.573 . . . . 0.0 110.684 161.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -81.55 -97.16 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 10.7 p30 -68.13 -17.26 64.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.539 -173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.71 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 87.4 mmm -52.96 -41.34 64.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.913 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 206' ' ' VAL . 44.6 m-85 -110.45 -33.64 6.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.591 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.447 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 6.7 mt-10 -49.89 -38.95 38.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -59.65 -45.9 90.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 64.2 mm-40 -84.15 -23.85 30.46 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.735 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.2 t -63.36 -56.06 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 94.6 mttt -57.44 -41.86 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.318 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -57.56 -43.36 84.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.678 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.66 -46.73 65.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.529 0.68 . . . . 0.0 110.74 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 88.3 mtp -65.73 -22.27 66.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.408 -175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 61.6 mtp180 -62.6 -27.14 68.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.114 0.483 . . . . 0.0 111.143 173.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -106.3 -3.26 21.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.073 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.694 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.8 m0 -56.15 112.38 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.367 0.603 . . . . 0.0 110.611 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 12.8 mmt180 -108.61 123.59 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.282 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -114.61 146.9 40.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.271 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 28.8 mt-10 -61.56 127.09 88.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.951 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 185' ' ' ASP . 12.8 Cg_exo -69.02 164.0 35.5 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.427 2.751 . . . . 0.0 112.12 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.02 41.28 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.546 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.449 ' HE2' ' HA2' ' A' ' 152' ' ' GLY . 22.6 mmmt -147.23 114.4 4.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.1 152.09 12.51 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.041 2.494 . . . . 0.0 111.399 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.58 113.63 1.02 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 181' ' ' ASP . 14.8 m -102.91 130.74 50.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.766 0.317 . . . . 0.0 111.473 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 72.43 49.89 18.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.717 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 mt -92.98 121.76 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.416 HG21 ' HE3' ' A' ' 177' ' ' LYS . 9.9 p -102.9 133.53 46.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.293 0.568 . . . . 0.0 111.057 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.64 156.62 42.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.958 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -124.28 119.36 29.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.293 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.3 mt -104.91 119.3 53.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.227 0.536 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.64 99.07 8.69 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.001 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.587 ' HA ' HG22 ' A' ' 236' ' ' THR . 64.2 m-85 -90.05 83.56 6.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.477 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.5 mmpt? -73.28 134.74 44.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.589 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 173' ' ' GLU . 20.3 tt -65.6 -2.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.64 0.733 . . . . 0.0 111.157 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.29 -18.8 63.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 26.07 6.82 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.029 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.0 p -134.49 167.37 20.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.879 0.371 . . . . 0.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 230' ' ' PHE . 2.1 p -144.25 154.75 43.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.64 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 21.4 tt0 -156.35 138.52 14.63 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.418 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 160' ' ' GLN . 2.5 mp -108.13 127.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.958 0.409 . . . . 0.0 109.999 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.927 -178.692 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.898 0.38 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.42 168.69 22.83 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.85 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.92 109.21 1.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 110.959 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -91.97 135.27 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.0 0.428 . . . . 0.0 110.314 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.62 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -85.58 126.47 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.638 0.732 . . . . 0.0 111.363 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 216' ' ' GLU . 2.9 mm? -88.24 -32.6 18.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.481 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 t -160.04 95.28 1.15 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.977 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.62 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 50.0 mtm180 -92.39 72.94 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.05 132.61 47.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.124 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -67.28 130.13 93.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.457 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 21.8 Cg_exo -62.93 148.19 93.75 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.341 2.027 . . . . 0.0 110.813 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -78.73 124.16 27.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.567 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.1 p90 -72.77 147.82 89.31 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.075 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 202' ' ' PHE . 9.6 Cg_endo -95.92 117.04 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.56 2.84 . . . . 0.0 111.771 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -62.88 -17.48 61.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.686 0.755 . . . . 0.0 109.736 174.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 170' ' ' LEU . 4.3 tpt180 -67.31 -34.33 77.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.308 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.08 -34.38 32.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 111.393 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -71.21 -27.66 63.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.32 0.581 . . . . 0.0 110.126 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -18.01 61.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.596 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.0 mp -95.57 3.08 54.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.146 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 20.0 mmt180 62.52 36.14 14.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.473 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 198' ' ' PRO . 14.5 mt -105.66 155.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.989 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 24.9 mt-10 -130.7 127.67 39.31 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -96.08 117.16 5.61 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.883 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -108.4 103.07 12.14 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -105.47 140.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.612 -175.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 194' ' ' LEU . 35.3 ttpt -121.68 115.66 23.14 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -121.66 146.34 26.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -171.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.3 ttmt -115.31 137.35 52.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.429 . . . . 0.0 109.871 171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.417 ' HB3' HG22 ' A' ' 191' ' ' VAL . 23.3 p90 -141.9 173.34 11.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.938 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -134.9 144.52 47.55 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 221' ' ' GLY . 3.2 m -114.51 149.57 16.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.615 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.713 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 27.6 p -87.47 172.07 8.65 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.718 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.713 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 32.0 Cg_endo -65.49 2.03 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.512 2.141 . . . . 0.0 111.575 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 187' ' ' ARG . 15.6 t70 -106.31 -3.53 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.354 0.597 . . . . 0.0 109.548 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 28.94 52.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.184 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 185' ' ' ASP . 53.7 mtt180 -101.39 129.52 47.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.777 0.322 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 213' ' ' TRP . 24.6 t -74.37 123.41 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.883 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -143.88 168.72 19.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.617 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 60.86 35.4 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.514 . . . . 0.0 111.058 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 180' ' ' PHE . 92.8 t -80.8 118.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.208 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -140.32 134.2 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.832 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -80.78 118.1 27.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.976 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 177' ' ' LYS . 14.6 mt -76.22 -37.86 57.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.338 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 t -158.2 146.09 18.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.307 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.1 146.46 18.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.542 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 21.1 mttm -59.19 -61.67 7.38 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.66 -175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.661 ' HB2' ' HB2' ' A' ' 201' ' ' MET . 3.4 Cg_exo -83.98 168.54 12.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.787 1.658 . . . . 0.0 111.253 166.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.21 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -92.06 -12.08 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.402 -0.186 . . . . 0.0 110.963 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 91.5 mmm -52.57 -37.37 57.78 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.607 0.567 . . . . 0.0 112.178 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 206' ' ' VAL . 59.0 m-85 -112.07 -32.06 6.69 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.3 OUTLIER -53.97 -38.47 65.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -174.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -64.38 -49.94 69.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.958 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -26.15 61.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 178' ' ' VAL . 60.6 t -58.97 -56.16 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.089 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 44.3 mtmt -57.34 -38.18 73.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -60.67 -42.18 96.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.705 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.82 -36.13 67.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.719 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 78.5 mmm -58.67 -31.57 68.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.0 110.702 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 38.4 mtm180 -70.35 -14.42 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -99.06 -16.91 18.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.678 ' HB2' HG21 ' A' ' 188' ' ' VAL . 26.9 m0 -58.06 113.48 1.92 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 111.157 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.05 123.74 47.77 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.287 0.565 . . . . 0.0 111.08 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -115.5 141.75 47.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.732 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.597 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.1 mt-10 -52.92 127.56 45.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.707 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 4.3 Cg_exo -74.03 150.92 44.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.33 2.687 . . . . 0.0 111.518 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.29 -6.92 34.49 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.056 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -140.74 109.91 6.65 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-O 120.835 0.35 . . . . 0.0 111.852 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.31 135.94 6.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.902 2.402 . . . . 0.0 112.053 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -129.55 124.5 4.48 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.1 p -110.07 143.11 40.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 0.0 111.35 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.65 51.29 7.3 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.928 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.65 116.82 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.24 133.22 55.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.892 0.377 . . . . 0.0 110.317 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -127.95 155.7 39.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.259 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -122.08 118.19 28.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.466 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' A' ' 176' ' ' VAL . 9.5 mt -107.09 125.21 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.006 0.431 . . . . 0.0 110.549 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.32 102.81 12.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.457 ' CD2' HG22 ' A' ' 236' ' ' THR . 74.8 m-85 -91.78 98.71 11.78 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.4 mmpt? -83.25 149.82 26.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.706 -175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.475 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.8 tt -54.02 -29.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.772 -168.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -70.18 -22.66 62.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 110.721 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.15 9.5 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.885 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.1 p -93.72 158.64 15.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 16.0 p -140.75 135.0 31.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.041 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 7.0 tp10 -136.73 144.14 43.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.053 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 228' ' ' ILE . 2.7 mp -124.32 130.71 73.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 111.084 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.252 1.216 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 178.04 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.972 0.415 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.15 -177.53 53.33 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.501 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.37 117.37 4.07 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.503 2.136 . . . . 0.0 110.932 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.01 136.21 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 215' ' ' TYR . . . -81.04 126.4 31.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.57 0.7 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 216' ' ' GLU . 1.0 OUTLIER -88.46 -27.64 21.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.566 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -161.71 92.7 0.88 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.511 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -92.92 74.08 4.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.685 0.755 . . . . 0.0 109.677 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -56.68 132.95 53.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.995 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' A' ' 238' ' ' ILE . 7.8 mm-40 -67.08 129.62 93.92 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.892 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.8 Cg_exo -62.14 161.17 27.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.566 2.177 . . . . 0.0 111.007 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -89.32 137.58 32.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -77.1 136.54 65.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.3 Cg_exo -79.85 136.12 11.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.054 2.502 . . . . 0.0 111.512 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . . . -60.91 -26.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.982 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -68.86 -38.7 79.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.819 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.43 -38.63 34.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.344 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 165' ' ' ALA . 20.5 pt20 -64.46 -37.81 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.065 0.46 . . . . 0.0 110.497 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 -14.21 60.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.445 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.04 2.33 51.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.27 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 171' ' ' ARG . 27.0 mmt180 59.18 42.26 18.95 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.592 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.443 HG21 ' HG3' ' A' ' 198' ' ' PRO . 21.9 mt -99.97 155.21 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 27.4 mt-10 -118.44 121.51 40.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.594 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -89.82 99.19 2.53 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.454 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 8.6 pt20 -97.73 100.92 12.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -109.15 138.87 34.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.6 ttpt -117.45 112.3 20.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -116.49 144.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -111.55 132.41 54.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.553 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -137.58 172.94 12.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.801 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 190' ' ' ASN . 4.4 p30 -139.42 142.42 37.46 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -110.93 151.31 13.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.016 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.9 p -85.0 165.26 37.91 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.176 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 43.7 Cg_endo -68.78 3.43 2.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.116 2.544 . . . . 0.0 111.726 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -110.32 -4.6 15.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 172.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.85 39.05 5.61 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.945 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.5 mmm180 -123.75 140.53 52.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 111.052 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -81.42 132.18 32.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.73 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -148.36 162.55 39.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.799 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.522 ' HB2' ' OD2' ' A' ' 181' ' ' ASP . 30.7 m-80 54.55 42.89 31.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.072 0.949 . . . . 0.0 110.594 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.725 HG11 ' HG3' ' A' ' 210' ' ' MET . 59.6 t -73.34 107.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -116.91 116.43 27.41 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.215 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -75.29 113.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.474 0.654 . . . . 0.0 109.579 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.1 mt -73.94 -37.73 64.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.338 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 m -160.03 154.72 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.698 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.69 174.0 15.61 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.971 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 32.5 tptt -71.33 -58.95 3.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.201 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.971 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.8 Cg_exo -82.98 -155.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.837 1.691 . . . . 0.0 109.421 162.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -121.06 -89.75 0.6 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.104 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -81.3 4.59 20.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.449 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 73.7 mmm -72.87 -35.44 67.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.683 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.5 m-85 -110.67 -26.78 9.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.606 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 4.2 mt-10 -50.99 -44.96 60.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -60.29 -43.34 96.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.594 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -27.71 51.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 109.994 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 210' ' ' MET . 46.0 t -65.09 -57.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 62.0 mttm -52.45 -41.45 63.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.292 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.03 -42.08 97.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -73.39 -38.97 65.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.725 ' HG3' HG11 ' A' ' 191' ' ' VAL . 82.3 mmm -59.26 -33.25 70.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.127 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -60.09 -26.76 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.102 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -92.05 -23.16 19.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.193 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.763 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.3 m0 -48.06 119.81 3.13 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.563 0.697 . . . . 0.0 112.678 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.23 119.94 29.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.324 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 155' ' ' ALA . 24.1 m-85 -124.54 139.94 53.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.464 ' HG3' HD11 ' A' ' 156' ' ' LEU . 19.3 mt-10 -51.77 118.36 11.47 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.713 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 14.4 Cg_endo -59.75 155.69 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.957 2.438 . . . . 0.0 111.738 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 219' ' ' LYS . . . 90.58 -8.08 80.36 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.075 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 218' ' ' GLY . 4.1 mppt? -132.98 110.21 12.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -87.52 149.35 7.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.729 2.286 . . . . 0.0 111.484 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.75 126.72 3.67 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.353 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.9 p -108.43 132.26 53.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.656 0.265 . . . . 0.0 111.707 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.64 48.73 27.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.959 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.4 126.35 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 178' ' ' VAL . 12.4 p -107.22 137.28 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.282 0.563 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.17 151.23 31.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.027 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -118.59 113.14 20.8 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.609 HD13 ' HG2' ' A' ' 161' ' ' PRO . 7.0 mt -103.07 120.83 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.218 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.26 99.26 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.603 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 90.2 m-85 -85.16 94.4 8.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.6 mmpt? -68.57 150.61 47.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.726 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.474 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 tt -57.59 -23.77 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.768 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -89.19 -4.25 58.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.153 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.4 29.64 6.59 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.754 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.3 p -107.07 163.83 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.232 0.516 . . . . 0.0 109.934 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.436 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 p -137.4 139.5 40.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.342 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -148.94 132.42 16.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.243 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 228' ' ' ILE . 1.7 mp -107.81 134.01 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 0.0 110.833 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 73.0 mt-30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.844 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.974 0.416 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.08 -179.76 25.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.442 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HB2' ' CD2' ' A' ' 215' ' ' TYR . 36.6 Cg_endo -72.02 119.22 6.04 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 111.966 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.058 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.65 107.84 19.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.945 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.76 -43.04 85.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.865 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 34.9 t -139.41 91.8 2.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.572 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.1 mtm180 -97.91 71.57 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 165.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.68 145.26 52.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.464 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -73.23 132.86 81.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.431 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' HD13 ' A' ' 228' ' ' ILE . 23.6 Cg_exo -62.74 147.61 94.48 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.528 2.152 . . . . 0.0 111.476 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.25 134.91 48.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.612 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.8 t80 -70.74 145.43 92.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 163' ' ' TYR . 4.8 Cg_endo -86.61 125.31 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.204 3.27 . . . . 0.0 111.69 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.01 72.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.309 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -66.24 -43.63 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.11 -26.6 65.89 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.91 -44.89 95.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.667 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.89 -25.41 61.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.0 mp -87.91 -4.98 58.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.4 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 171' ' ' ARG . 16.9 mmt180 53.91 41.08 32.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.543 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.6 mt -88.46 150.99 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.238 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 1.1 mp0 -111.19 110.84 21.53 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -74.55 143.18 31.13 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.855 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 3.7 pt20 -152.6 102.17 2.7 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.9 m -110.71 143.36 20.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.364 0.602 . . . . 0.0 110.786 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -124.97 104.22 8.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.758 HG22 HG13 ' A' ' 193' ' ' ILE . 3.7 t -113.18 144.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -171.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 194' ' ' LEU . 33.2 ttmt -117.49 133.36 56.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -140.03 174.15 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.432 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 222' ' ' SER . 9.1 m-20 -136.72 126.8 26.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.652 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.52 149.86 8.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.401 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 36.9 p -85.58 169.48 15.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.34 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.6 Cg_endo -65.65 4.84 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.563 2.175 . . . . 0.0 111.405 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 183' ' ' THR . 6.2 m-20 -104.64 -12.89 16.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.39 31.49 13.65 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.776 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.502 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 1.9 ppt_? -113.7 138.36 50.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.2 0.524 . . . . 0.0 110.574 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 213' ' ' TRP . 20.8 t -78.64 134.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.266 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -151.91 167.0 29.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.81 36.7 19.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.4 t -78.72 119.46 27.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.695 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -138.64 126.58 22.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.624 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.758 HG13 HG22 ' A' ' 178' ' ' VAL . 2.1 mp -73.75 114.69 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -76.8 -39.89 49.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.083 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -156.98 153.21 27.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.545 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -154.48 170.31 21.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.714 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.4 tmtp? -67.43 -60.21 6.06 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -91.05 -153.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.428 2.086 . . . . 0.0 110.318 164.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -107.27 -88.8 0.46 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.909 -0.495 . . . . 0.0 111.15 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -88.25 -5.47 58.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.535 0.207 . . . . 0.0 110.668 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.409 ' HB2' ' HG2' ' A' ' 198' ' ' PRO . 80.8 mmm -58.11 -34.92 70.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.851 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 206' ' ' VAL . 22.9 m-85 -110.96 -29.55 7.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 19.9 mt-10 -48.66 -39.94 26.17 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -55.91 -51.53 67.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.499 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 1.8 mp0 -79.45 -26.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.47 -174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -64.13 -55.98 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.685 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 98.9 mttt -57.79 -39.46 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.604 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.06 -46.04 75.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.385 0.612 . . . . 0.0 110.35 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.02 76.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.516 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 87.1 mtp -65.42 -21.54 66.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.933 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 36.6 mtp180 -72.8 -17.93 61.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.072 0.463 . . . . 0.0 110.27 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -100.14 -15.3 18.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.918 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.587 ' HB2' HG21 ' A' ' 188' ' ' VAL . 40.8 m0 -56.88 129.29 40.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.109 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -128.04 132.21 49.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.572 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 153' ' ' PRO . 32.9 m-85 -115.56 152.62 32.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.18 176.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.98 124.81 60.64 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 123.583 0.552 . . . . 0.0 111.648 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.4 81.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.636 2.224 . . . . 0.0 111.547 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.52 34.47 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.505 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -134.62 110.99 11.38 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.914 0.388 . . . . 0.0 111.848 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -89.66 152.44 5.17 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.1 2.533 . . . . 0.0 111.754 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -140.68 127.65 3.52 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 181' ' ' ASP . 8.0 t -112.07 136.75 51.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.214 0.53 . . . . 0.0 110.998 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 65.91 44.24 92.2 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.184 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.4 mt -85.86 117.95 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.68 130.45 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.446 0.641 . . . . 0.0 110.769 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.24 147.11 27.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.425 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.05 114.77 22.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.395 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.6 mt -102.79 106.76 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.265 0.555 . . . . 0.0 110.063 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.3 mm? -88.43 98.81 11.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.887 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.77 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 87.8 m-85 -86.69 98.21 11.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 22.3 mmtp -67.03 141.45 57.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.394 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.02 -15.2 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.747 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -17.47 62.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.45 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 107.73 2.07 34.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.899 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 66.6 p -89.78 174.76 7.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.165 0.507 . . . . 0.0 110.487 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.9 p -142.1 141.22 32.69 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.816 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 37.0 tt0 -140.7 134.81 30.89 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.625 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -118.26 132.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.025 0.441 . . . . 0.0 111.213 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.163 176.065 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 100.98 153.0 26.22 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.874 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.91 143.68 9.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.127 2.551 . . . . 0.0 112.746 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -84.63 137.43 33.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.92 127.61 35.36 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.237 0.541 . . . . 0.0 111.174 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 216' ' ' GLU . 7.3 mp -96.98 -31.44 12.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.385 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.4 t -141.16 100.91 3.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.794 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -114.17 57.24 0.7 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.493 HD21 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p-10 -62.35 127.68 32.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.449 -175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -75.03 129.07 83.83 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.097 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 205' ' ' GLU . 17.5 Cg_exo -60.98 157.22 39.9 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.743 2.296 . . . . 0.0 111.932 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.27 137.85 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.8 p90 -77.98 130.32 73.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 4.5 Cg_exo -81.56 137.43 10.25 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.406 2.737 . . . . 0.0 112.267 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.16 66.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.964 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 170' ' ' LEU . 63.8 mtp180 -58.04 -49.62 76.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.206 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.95 -32.59 69.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.002 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.55 -33.55 72.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.53 -20.45 60.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.567 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 166' ' ' ARG . 8.6 mp -89.6 -1.01 57.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.089 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 61.19 39.06 16.29 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.522 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 173' ' ' GLU . 19.9 mt -99.72 156.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' N ' HG22 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -122.71 122.51 38.93 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.54 142.81 43.0 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.217 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 7.4 tt0 -154.31 103.66 2.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.573 HG22 ' HE1' ' A' ' 230' ' ' PHE . 5.8 m -124.94 127.66 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.243 0.544 . . . . 0.0 111.982 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -103.51 110.74 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -115.71 144.84 22.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.491 -172.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -110.28 137.61 47.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.513 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.72 171.58 14.0 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 68.8 m-20 -129.96 153.77 48.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.25 148.64 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 5.8 p -86.34 166.94 25.5 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 57.7 Cg_endo -71.47 14.86 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.699 2.266 . . . . 0.0 111.175 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 183' ' ' THR . 35.9 t70 -110.31 -9.26 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.15 24.71 33.62 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.466 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -106.09 138.48 42.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.119 0.485 . . . . 0.0 111.304 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 213' ' ' TRP . 18.1 t -84.59 136.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.75 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -156.69 173.15 17.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.391 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 61.29 33.87 18.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.097 0.559 . . . . 0.0 111.263 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 210' ' ' MET . 84.1 t -77.07 117.28 21.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.158 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -133.0 124.25 27.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.365 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -74.76 121.13 25.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 0.0 110.089 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.3 mt -85.4 -43.42 13.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.966 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.799 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -159.03 163.22 36.57 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.963 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.979 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 15.2 tptp -64.5 -59.0 11.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 5.3 Cg_endo -92.89 -143.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.861 2.374 . . . . 0.0 109.789 164.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.67 -96.29 0.47 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.399 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 1.1 m-80 -70.58 -17.31 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.196 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.2 mmm -54.17 -36.56 63.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.471 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 206' ' ' VAL . 27.7 m-85 -110.66 -27.89 8.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.825 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 22.8 mt-10 -50.61 -31.72 16.82 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.292 0.37 . . . . 0.0 111.593 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.26 -58.34 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -74.57 -21.94 59.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -172.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.71 ' O ' ' HG2' ' A' ' 210' ' ' MET . 48.4 t -66.73 -57.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -61.53 -34.01 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.569 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -64.01 -35.64 81.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.689 0.281 . . . . 0.0 110.377 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.43 -41.33 69.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.71 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 81.5 mmm -60.25 -28.14 67.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.949 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 211' ' ' ARG . 53.0 mtt180 -67.61 -19.08 65.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.961 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HB2' HD21 ' A' ' 159' ' ' ASN . 24.9 mtp180 -100.52 -17.4 17.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.377 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.698 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.6 m0 -58.68 137.93 57.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.292 0.568 . . . . 0.0 111.166 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -132.84 138.45 47.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.321 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.8 161.93 27.05 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.646 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.441 ' N ' HD13 ' A' ' 156' ' ' LEU . 50.7 mt-10 -49.83 124.17 15.98 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.901 0.751 . . . . 0.0 111.701 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.21 140.11 57.82 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.016 1.811 . . . . 0.0 110.364 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.9 62.42 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -121.5 98.86 45.83 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.682 0.277 . . . . 0.0 111.599 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.24 144.33 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.857 2.371 . . . . 0.0 112.207 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -146.12 146.13 15.88 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 23.2 t -129.42 144.84 51.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.385 0.592 . . . . 0.0 111.487 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.29 40.06 50.16 Favored Glycine 0 CA--C 1.508 -0.384 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.027 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.56 118.22 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.59 134.01 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.17 0.51 . . . . 0.0 111.548 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.87 149.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.681 174.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.636 ' HB3' HE21 ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.73 113.86 20.82 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.461 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 238' ' ' ILE . 3.8 mt -100.71 122.64 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.544 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.642 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.4 mm? -104.88 110.49 22.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.195 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.573 ' HE1' HG22 ' A' ' 176' ' ' VAL . 24.1 m-85 -102.17 82.7 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.6 mmpt? -68.8 146.67 52.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.135 0.493 . . . . 0.0 110.741 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.22 -18.74 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.344 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.7 -4.02 47.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.89 34.03 4.78 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.795 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 82.5 p -125.87 163.59 22.6 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.366 -0.491 . . . . 0.0 110.621 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 39.1 p -138.89 150.96 46.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -157.57 140.73 15.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 228' ' ' ILE . 1.5 mp -107.19 131.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 0.0 110.357 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 227' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.862 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.63 -176.46 21.51 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.8 100.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.287 1.991 . . . . 0.0 110.678 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -106.99 127.98 53.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.992 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.562 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -75.86 123.37 25.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.786 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 216' ' ' GLU . 90.0 mt -84.07 -32.23 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.592 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 92.94 1.45 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.06 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.562 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 71.5 mtm180 -95.17 70.88 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.8 131.23 47.16 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.718 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 4.2 mm-40 -63.47 130.5 94.34 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.262 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.76 154.95 51.72 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.286 1.991 . . . . 0.0 111.473 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.5 tp60 -83.89 108.39 16.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.75 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.1 p90 -68.03 131.18 92.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.3 Cg_exo -80.54 145.6 16.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.521 2.814 . . . . 0.0 112.448 -169.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -65.56 -22.18 66.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.293 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -68.46 -33.85 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.98 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -82.35 -38.93 23.5 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.399 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.1 pt20 -62.74 -38.92 92.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 110.16 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.86 -13.57 61.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.65 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.8 mm? -103.69 -0.84 28.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HB3' HD11 ' A' ' 232' ' ' ILE . 67.8 mmt-85 58.48 40.24 24.17 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.572 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.624 HG13 ' HB3' ' A' ' 170' ' ' LEU . 11.7 mt -87.73 123.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.3 mt-10 -85.48 120.55 27.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.513 170.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . -98.47 98.37 2.02 Favored Glycine 0 C--O 1.217 -0.963 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.723 ' HG3' ' HB2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -103.21 102.4 12.38 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.2 138.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.327 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 194' ' ' LEU . 84.7 tttt -118.15 115.31 24.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 193' ' ' ILE . 3.2 t -119.62 144.0 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.993 0.425 . . . . 0.0 111.823 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 194' ' ' LEU . 30.5 ttmt -116.58 124.05 48.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.404 169.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -133.29 174.05 10.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 110.801 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.74 148.98 49.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.194 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.5 m -125.79 144.44 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 22.8 p -82.6 164.77 45.68 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.605 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 36.4 Cg_endo -65.61 3.07 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.788 2.325 . . . . 0.0 111.728 174.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.38 -18.45 16.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 109.724 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.94 4.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.639 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 17.2 mmt180 -113.14 129.54 56.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.774 0.321 . . . . 0.0 111.563 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.7 t -79.33 130.29 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.953 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.76 173.43 16.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 58.32 34.45 24.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.703 0.763 . . . . 0.0 110.91 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.57 121.41 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.0 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -134.87 132.68 38.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.419 0.628 . . . . 0.0 110.097 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 178' ' ' VAL . 2.7 mp -83.09 116.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.4 mt -79.23 -32.12 43.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.935 -174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.7 t -164.12 148.37 9.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.509 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -146.76 167.02 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 21.1 tptm -69.74 -60.87 3.43 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.5 Cg_endo -90.36 -168.12 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.299 1.999 . . . . 0.0 111.447 168.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -93.71 -87.59 0.24 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.276 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -91.64 -8.14 48.01 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.304 -0.247 . . . . 0.0 111.313 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 93.4 mmm -54.0 -48.76 70.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.86 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 206' ' ' VAL . 36.9 m-85 -111.11 -32.15 6.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 193' ' ' ILE . 2.0 tm-20 -56.12 -33.52 65.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.58 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -73.37 -40.02 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.465 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -24.26 40.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.895 0.378 . . . . 0.0 110.108 -173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 202' ' ' PHE . 57.3 t -60.44 -55.77 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.495 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 58.4 mtpt -56.25 -41.98 76.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.694 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -59.86 -42.24 93.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.23 -39.06 63.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.428 . . . . 0.0 111.101 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 89.1 mtp -65.53 -22.11 66.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.422 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 45.6 mtp180 -67.74 -19.08 65.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.32 173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 212' ' ' ARG . 25.7 mtm180 -100.83 -13.86 18.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.891 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.734 ' HB2' HG21 ' A' ' 188' ' ' VAL . 32.2 m0 -54.32 127.67 28.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 110.729 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.471 ' HD2' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -118.08 126.63 52.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.147 -176.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -116.36 151.1 36.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.788 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.528 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 44.0 mt-10 -63.97 123.36 81.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.365 0.416 . . . . 0.0 111.464 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.93 152.33 71.44 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.472 2.781 . . . . 0.0 112.417 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.01 -6.86 56.86 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.531 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.83 107.07 10.62 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.413 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.1 Cg_endo -86.92 152.08 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.863 2.376 . . . . 0.0 111.765 170.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -149.53 105.04 0.29 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.993 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 19.6 m -100.11 134.62 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.217 -177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.8 46.29 7.91 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.4 mt -94.93 120.42 44.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.85 133.81 40.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.219 0.533 . . . . 0.0 110.943 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.19 153.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.223 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -120.86 118.15 29.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.8 mt -105.91 118.81 54.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.848 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.8 mm? -104.34 98.08 7.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.065 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 78.3 m-85 -85.28 93.65 8.74 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 229' ' ' LEU . 39.4 mmtt -65.49 153.48 41.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.113 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -56.76 -25.65 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.693 -168.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.87 4.18 48.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.642 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.17 35.71 6.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.663 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 41.5 p -119.02 171.72 8.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.827 0.314 . . . . 0.0 110.161 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.478 HG22 ' CD1' ' A' ' 230' ' ' PHE . 63.6 p -127.72 164.62 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.428 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 29.3 tt0 -163.6 134.2 4.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.29 125.21 74.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.406 0.622 . . . . 0.0 110.965 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 77.7 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.734 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.53 -167.31 38.79 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.349 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.93 101.18 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.647 2.231 . . . . 0.0 110.749 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.81 132.31 42.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.888 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 106.87 6.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.84 -37.33 84.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.1 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 t -163.89 103.46 0.9 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.083 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.9 88.01 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.51 0.671 . . . . 0.0 110.058 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.57 134.77 49.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.469 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 238' ' ' ILE . 9.0 mt-30 -80.87 131.5 60.02 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.396 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 24.4 Cg_exo -59.98 155.51 44.04 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.827 2.351 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 7.5 tt0 -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.583 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 37.5 p90 -93.24 138.57 23.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' CE1' ' A' ' 202' ' ' PHE . 9.4 Cg_endo -94.1 128.37 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.842 3.028 . . . . 0.0 112.381 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.62 65.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.1 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 170' ' ' LEU . 67.1 mtp180 -52.74 -50.77 62.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.433 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -71.92 -31.05 65.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -67.37 -36.8 82.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.49 -19.2 61.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.2 mm? -91.44 -4.84 55.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.331 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.664 ' HD2' HD11 ' A' ' 232' ' ' ILE . 18.5 mmt180 59.91 43.98 14.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.675 HG21 ' HG3' ' A' ' 198' ' ' PRO . 18.3 mt -100.54 130.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.94 113.5 27.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.463 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.19 111.95 3.6 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.829 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 10.0 pt20 -107.57 103.72 13.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 228' ' ' ILE . 7.0 m -107.01 122.68 61.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.519 0.676 . . . . 0.0 110.982 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -104.87 107.95 19.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.628 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.653 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.32 143.16 34.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -170.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -109.78 136.07 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -143.97 172.74 12.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.317 0.579 . . . . 0.0 111.136 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -126.97 162.35 26.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.372 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.29 130.41 60.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 17.1 p -71.33 164.33 58.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.723 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 220' ' ' PRO . 6.7 Cg_endo -50.69 -35.71 48.4 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 122.047 1.831 . . . . 0.0 111.135 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.24 -14.69 62.32 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.164 0.507 . . . . 0.0 111.13 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.04 32.75 6.02 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.988 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 214' ' ' ARG . 21.6 mmm180 -117.99 128.84 55.18 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.722 0.772 . . . . 0.0 111.699 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 213' ' ' TRP . 44.3 t -76.08 128.68 37.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.513 -1.222 . . . . 0.0 111.51 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.65 171.36 17.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.251 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 62.87 30.96 16.57 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 110.113 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 210' ' ' MET . 92.2 t -76.56 115.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -133.27 121.91 23.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.007 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 178' ' ' VAL . 2.9 mp -75.83 116.23 18.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.913 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.0 mt -78.58 -36.4 44.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.077 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.9 t -159.25 147.04 17.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.457 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -152.05 151.97 31.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.079 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 25.9 tptp -63.26 -67.42 1.09 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.079 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -96.51 171.12 0.99 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.412 2.075 . . . . 0.0 111.118 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -95.12 -83.77 0.35 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.932 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -72.76 4.05 4.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 59.7 mtp -91.91 -48.28 6.85 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.094 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 206' ' ' VAL . 77.4 m-85 -111.09 -43.94 3.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.92 -36.03 59.1 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.383 0.427 . . . . 0.0 111.441 -174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -67.79 -43.78 78.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.348 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 162' ' ' GLN . 15.6 mm-40 -74.91 -24.82 58.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.562 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 210' ' ' MET . 61.5 t -61.18 -55.19 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -49.41 -48.82 46.87 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.475 0.485 . . . . 0.0 111.061 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.556 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 94.8 m-20 -58.79 -37.96 77.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.469 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -75.5 -39.62 58.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.58 0.228 . . . . 0.0 110.688 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.0 mmm -60.64 -35.25 75.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' A' ' 208' ' ' ASN . 69.5 mtp180 -60.59 -18.89 55.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.636 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -105.37 -14.05 15.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.511 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.649 ' HB2' HG21 ' A' ' 188' ' ' VAL . 27.7 m0 -54.85 137.75 44.4 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.456 0.646 . . . . 0.0 111.718 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 187' ' ' ARG . 24.9 mmt180 -121.0 132.68 55.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.394 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.77 164.25 16.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.366 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.36 134.78 91.21 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.413 0.446 . . . . 0.0 110.849 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.78 139.0 10.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.612 2.208 . . . . 0.0 111.676 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.89 -5.54 34.59 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -131.38 110.07 15.02 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 92.5 Cg_endo -93.24 144.74 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.929 174.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -127.85 151.34 18.6 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 49.8 m -143.85 135.62 26.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.657 0.729 . . . . 0.0 111.6 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 70.28 51.77 20.7 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.224 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.86 119.41 53.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.4 133.53 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.86 165.09 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.443 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -123.33 122.16 37.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.855 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 176' ' ' VAL . 9.0 mt -103.02 110.34 29.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.665 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 1.7 mm? -95.03 99.77 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.25 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 236' ' ' THR . 76.5 m-85 -85.91 98.34 10.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 22.9 mmtp -73.17 157.14 37.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.108 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 171' ' ' ARG . 16.8 tt -58.8 -26.62 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.588 -166.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.92 -22.34 45.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 113.98 29.79 2.72 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.806 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 81.9 p -99.63 162.69 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 230' ' ' PHE . 31.3 p -132.19 139.76 48.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.767 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.0 tt0 -144.74 134.35 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.444 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -111.92 125.32 69.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.569 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.459 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.117 0.484 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.99 -164.28 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.149 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.817 ' HB3' ' HE2' ' A' ' 215' ' ' TYR . 91.5 Cg_exo -45.24 144.36 4.39 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.594 2.863 . . . . 0.0 113.844 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -138.72 126.4 22.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.572 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -104.62 107.81 18.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 216' ' ' GLU . 6.8 mp -58.19 -42.5 86.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.745 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 32.0 t -129.59 88.46 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.576 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -93.96 59.82 2.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -72.99 151.07 41.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.347 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.473 ' NE2' HD12 ' A' ' 238' ' ' ILE . 5.9 mm-40 -79.3 135.09 57.94 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.819 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 20.9 Cg_exo -62.35 162.61 23.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.886 2.391 . . . . 0.0 111.233 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 8.7 tt0 -83.66 130.15 34.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 44.5 p90 -86.39 141.03 34.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.679 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 8.3 Cg_endo -93.9 127.48 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.725 2.95 . . . . 0.0 111.489 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -63.08 -19.34 64.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 109.959 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 170' ' ' LEU . 50.1 ttt180 -61.65 -42.26 98.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.818 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.49 -40.64 66.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.97 0.414 . . . . 0.0 111.469 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.0 pt20 -67.94 -28.82 67.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.339 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.13 61.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.772 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -94.61 3.64 54.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.307 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.24 38.44 5.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.848 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 198' ' ' PRO . 9.8 mt -110.05 152.71 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.279 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 172' ' ' ILE . 22.1 mt-10 -125.51 119.39 28.07 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 172.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -82.82 104.85 2.59 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.932 -1.128 . . . . 0.0 113.021 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 12.8 mt-30 -96.93 102.91 14.78 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.1 m -107.34 138.18 34.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.361 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.603 ' HG2' HD12 ' A' ' 194' ' ' LEU . 4.6 ttmp? -117.21 114.07 23.13 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 2.6 t -121.46 143.92 32.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.537 -172.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -108.5 134.72 50.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 168.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -138.26 172.98 12.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.246 0.546 . . . . 0.0 110.418 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 52.0 m-20 -133.02 160.74 36.28 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.0 m -131.18 148.19 32.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 14.7 p -85.68 166.06 31.9 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.021 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.7 Cg_endo -65.28 2.04 1.7 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.773 2.315 . . . . 0.0 111.991 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.42 -9.42 23.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.324 0.583 . . . . 0.0 109.642 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 215' ' ' TYR . . . 88.69 35.14 8.62 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.869 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 22.8 mmm180 -113.23 128.91 56.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.2 0.524 . . . . 0.0 111.775 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 213' ' ' TRP . 34.4 t -75.85 128.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.572 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.69 173.12 16.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 60.8 33.66 19.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.375 0.607 . . . . 0.0 110.918 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.56 117.22 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.802 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -125.18 114.0 18.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.757 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -74.37 113.61 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.407 0.622 . . . . 0.0 109.366 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' LYS . 13.9 mt -78.61 -34.31 46.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.085 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.3 t -168.96 160.23 9.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.589 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -158.45 172.89 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.601 ' CB ' ' HD3' ' A' ' 198' ' ' PRO . 13.1 mmtm -70.16 -64.38 1.43 Allowed Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.035 174.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 197' ' ' LYS . 3.8 Cg_exo -84.44 -154.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.052 1.835 . . . . 0.0 109.744 164.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -132.34 -82.46 0.49 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.897 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.4 -14.62 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.2 tpp -62.28 -51.97 65.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.49 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 206' ' ' VAL . 61.9 m-85 -108.48 -32.8 7.27 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -170.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.466 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 2.2 tm-20 -57.78 -19.97 32.0 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.442 0.464 . . . . 0.0 111.763 -171.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -76.43 -56.11 4.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.811 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 162' ' ' GLN . 4.3 tp10 -73.67 -20.0 60.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -169.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 48.0 t -59.44 -57.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.717 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -55.22 -44.2 75.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -58.25 -44.17 88.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -72.51 -34.08 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 0.0 110.817 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 92.6 mtp -67.8 -25.21 65.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.834 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 211' ' ' ARG . 55.4 mtt180 -68.46 -21.9 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.472 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -85.04 -20.97 29.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.761 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.735 ' HB2' HG21 ' A' ' 188' ' ' VAL . 43.7 m0 -58.72 111.09 1.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.398 0.618 . . . . 0.0 110.857 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 17.9 mmt180 -98.0 126.79 43.58 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.215 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.817 ' HE2' ' HB3' ' A' ' 153' ' ' PRO . 32.4 t80 -115.84 150.44 37.0 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.371 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 156' ' ' LEU . 26.3 mt-10 -60.66 131.43 91.01 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 121.37 0.605 . . . . 0.0 112.185 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.55 141.34 17.57 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.597 2.198 . . . . 0.0 111.538 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.08 -6.94 35.0 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.553 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.701 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 74.2 mmtt -129.07 122.18 21.1 Favored Pre-proline 0 C--O 1.224 -0.288 0 CA-C-O 120.593 0.235 . . . . 0.0 110.462 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -95.6 149.05 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.867 2.378 . . . . 0.0 111.92 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -131.5 146.05 17.58 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 48.6 m -142.54 130.1 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.061 0.457 . . . . 0.0 111.297 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 47.49 13.41 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.111 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' A' ' 221' ' ' GLY . 1.8 mt -100.57 123.73 53.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.48 141.43 21.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.272 0.558 . . . . 0.0 111.333 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.33 148.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.773 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.8 t30 -118.52 119.88 35.84 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.516 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.624 HG23 HG13 ' A' ' 238' ' ' ILE . 7.8 mt -106.48 124.43 61.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.776 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.554 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.9 mm? -103.79 99.56 9.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.933 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.536 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 89.1 m-85 -85.71 95.78 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.0 mmpt? -70.76 150.31 46.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.406 0.622 . . . . 0.0 111.416 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.7 tp -52.18 -31.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.125 -172.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -81.81 -19.84 40.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.626 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 115.34 6.23 18.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.404 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.2 p -90.44 164.59 14.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.483 0.641 . . . . 0.0 109.326 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 230' ' ' PHE . 3.1 p -141.55 160.24 40.56 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.111 0.481 . . . . 0.0 111.914 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 tt0 -151.11 135.56 16.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 228' ' ' ILE . 3.1 mt -115.79 125.71 73.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.149 0.5 . . . . 0.0 110.675 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 79.2 mt-30 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.113 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.914 0.388 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.58 168.14 33.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.071 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 215' ' ' TYR . 93.6 Cg_endo -90.44 167.58 4.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.134 2.556 . . . . 0.0 112.063 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -96.99 137.49 36.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 110.629 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.646 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -88.94 128.29 35.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.341 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 216' ' ' GLU . 2.1 mm? -95.53 -34.15 12.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.787 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 35.0 t -147.77 78.13 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.064 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.646 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 49.3 mtm180 -85.81 60.56 6.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 167.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.97 130.22 42.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.304 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.65 131.81 91.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.214 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.413 ' CD ' HD13 ' A' ' 228' ' ' ILE . 21.0 Cg_exo -61.29 157.26 41.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.537 2.158 . . . . 0.0 110.848 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -79.87 119.31 22.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.633 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 19.9 p90 -60.79 130.42 90.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 5.8 Cg_exo -78.93 135.49 12.54 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.218 2.612 . . . . 0.0 111.946 -170.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.64 -24.78 67.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -64.53 -45.0 89.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.79 64.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -69.03 -30.35 68.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.12 -20.16 60.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.317 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 170' ' ' LEU . 3.1 mm? -97.71 -1.61 43.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.74 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 59.63 42.78 16.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.364 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 173' ' ' GLU . 31.1 mt -98.92 154.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.493 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -115.41 117.07 29.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -85.13 118.51 4.79 Favored Glycine 0 C--O 1.22 -0.724 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.318 -170.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 18.4 tt0 -107.7 103.67 13.01 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 196' ' ' ALA . 3.4 m -113.86 120.97 65.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.636 0.732 . . . . 0.0 111.257 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 194' ' ' LEU . 59.3 tttp -103.05 109.08 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.731 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 206' ' ' VAL . 2.2 t -119.31 142.28 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.675 0.274 . . . . 0.0 111.458 -172.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 223' ' ' GLY . 0.5 OUTLIER -109.36 142.43 40.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 169.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -147.04 173.7 12.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.174 0.511 . . . . 0.0 110.241 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 24.0 m-20 -134.02 160.49 37.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 153' ' ' PRO . 2.8 m -131.03 149.66 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.515 174.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.6 p -81.1 171.08 13.13 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.513 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 24.1 Cg_endo -62.23 -7.5 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.354 2.036 . . . . 0.0 111.787 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.75 -5.45 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 82.62 32.63 26.99 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.046 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 23.5 mmt180 -106.26 131.49 53.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 110.539 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 213' ' ' TRP . 26.1 t -76.76 127.14 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.475 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.04 171.59 16.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.321 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.14 38.46 20.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.226 0.536 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.05 114.59 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.8 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -131.43 122.58 26.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.058 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.501 ' CG1' ' HG2' ' A' ' 203' ' ' GLU . 2.7 mp -76.25 116.57 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.852 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 177' ' ' LYS . 12.5 mt -81.77 -35.56 29.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.433 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.5 t -156.95 148.46 22.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.307 -176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -156.6 156.31 33.33 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.762 ' HB2' ' HD3' ' A' ' 198' ' ' PRO . 16.4 mmtp -60.63 -66.06 1.76 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.762 ' HD3' ' HB2' ' A' ' 197' ' ' LYS . 5.8 Cg_exo -85.11 -147.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 110.191 166.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.47 -96.14 0.47 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.025 -0.422 . . . . 0.0 111.045 175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.0 p30 -77.8 -7.76 57.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.864 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 69.2 mtp -61.51 -32.96 73.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.7 m-85 -110.65 -38.75 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 23.2 mt-10 -47.44 -35.28 8.28 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.382 0.426 . . . . 0.0 111.944 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.5 -56.85 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.521 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.16 -28.03 61.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.22 -59.32 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 9.7 mtmp? -58.72 -37.56 76.43 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.57 -32.08 72.59 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.64 36.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 74.5 mmm -57.53 -33.76 68.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 65.8 mtp85 -68.65 -15.46 63.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 0.0 111.11 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -101.01 -12.34 18.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.655 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.705 ' HB2' HG21 ' A' ' 188' ' ' VAL . 28.8 m0 -58.15 121.2 10.12 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.31 0.576 . . . . 0.0 110.004 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.18 125.23 52.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.571 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 153' ' ' PRO . 33.6 m-85 -116.83 140.34 49.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.356 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 42.3 mt-10 -52.56 129.75 44.61 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.673 0.608 . . . . 0.0 111.509 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 2.8 Cg_endo -75.97 155.51 38.55 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.23 2.62 . . . . 0.0 111.338 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.0 33.24 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.042 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -150.01 122.54 4.24 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.835 0.35 . . . . 0.0 111.333 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.54 152.31 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.96 2.44 . . . . 0.0 111.813 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 182' ' ' VAL . . . -124.92 130.9 7.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 35.4 m -118.53 125.42 49.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.603 0.239 . . . . 0.0 111.481 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 179' ' ' LYS . . . 72.66 60.71 3.86 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.227 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 117.32 49.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.22 132.49 51.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.419 0.628 . . . . 0.0 111.036 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.27 152.1 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.648 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.66 117.52 23.69 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 8.9 mt -101.34 119.75 49.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.126 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.858 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.7 mm? -97.26 99.12 10.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.957 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 95.5 m-85 -86.5 84.52 7.4 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 25.1 mmtp -65.43 141.57 58.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.916 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.03 -13.35 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.642 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.57 -8.42 57.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.668 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.87 -0.23 41.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.183 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 51.8 p -96.48 157.79 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.105 0.453 . . . . 0.0 110.186 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 p -132.65 134.14 44.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.045 0.45 . . . . 0.0 110.527 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 229' ' ' LEU . 11.1 mt-10 -128.54 152.37 48.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.328 -173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.2 mp -132.83 125.61 52.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.008 175.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.864 178.227 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.2 54.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.34 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.519 ' HB2' ' HE2' ' A' ' 215' ' ' TYR . 38.0 Cg_endo -74.94 143.87 29.8 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.533 1.488 . . . . 0.0 111.167 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 216' ' ' GLU . 35.6 ttm180 -133.33 116.82 16.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.195 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.14 106.47 12.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.507 HD13 ' CG ' ' A' ' 216' ' ' GLU . 16.0 tp -52.81 -35.23 56.63 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.595 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -141.38 81.96 1.8 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.386 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 0.0 OUTLIER -86.99 67.1 9.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.673 0.749 . . . . 0.0 109.76 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.25 127.67 32.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.301 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' HA ' HD11 ' A' ' 238' ' ' ILE . 49.7 mt-30 -70.0 129.37 90.92 Favored Pre-proline 0 N--CA 1.436 -1.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.332 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.646 ' HG2' HD13 ' A' ' 228' ' ' ILE . 17.2 Cg_exo -61.86 161.53 25.16 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.338 2.692 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.18 130.5 34.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 40.8 p90 -66.18 136.78 95.43 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.0 Cg_exo -80.46 126.63 6.18 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.301 2.667 . . . . 0.0 112.091 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -60.65 -28.06 68.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.495 ' O ' HD13 ' A' ' 170' ' ' LEU . 27.9 ptt180 -67.71 -32.65 73.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.233 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.81 -40.42 18.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.911 0.386 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -64.24 -32.65 74.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.656 -178.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.92 -17.93 60.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.559 0.695 . . . . 0.0 110.166 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 166' ' ' ARG . 6.0 mp -99.6 2.79 44.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.554 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 61.78 44.42 8.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.287 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' ' 198' ' ' PRO . 11.4 mt -108.5 157.28 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.933 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 7.3 pt-20 -124.11 120.69 33.09 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -92.43 99.97 2.6 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.827 -173.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 101.81 14.0 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.0 m -106.84 140.78 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.334 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HG2' HD12 ' A' ' 194' ' ' LEU . 22.5 ttpt -119.96 108.59 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.626 HG22 HG13 ' A' ' 193' ' ' ILE . 3.3 t -112.65 142.86 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.948 -172.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD11 ' A' ' 194' ' ' LEU . 39.9 ttmt -110.05 132.54 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.782 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.98 172.69 12.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.336 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -132.61 155.22 49.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 3.6 m -131.4 151.03 34.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.173 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.0 p -83.66 167.44 28.35 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.611 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 34.5 Cg_endo -65.53 3.24 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.434 . . . . 0.0 112.165 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.43 8.6 10.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.0 110.888 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.79 51.25 4.89 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.654 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 57.1 mmt-85 -115.46 127.87 55.63 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.587 -0.36 . . . . 0.0 110.655 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 213' ' ' TRP . 27.2 t -75.08 121.34 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.173 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.35 163.61 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.829 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 62.14 35.49 15.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.072 0.463 . . . . 0.0 111.235 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.03 115.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.196 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.18 124.31 24.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.626 HG13 HG22 ' A' ' 178' ' ' VAL . 2.5 mp -72.02 113.5 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 179' ' ' LYS . 21.5 mt -70.67 -36.82 73.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.802 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.3 t -176.58 156.6 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.729 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -147.31 171.55 15.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.927 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.9 tttp -61.21 -57.45 25.75 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.826 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 1.9 Cg_endo -88.48 175.47 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.962 1.775 . . . . 0.0 110.739 163.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.3 -93.09 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.693 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -79.45 5.18 13.41 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.808 0.337 . . . . 0.0 111.428 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -75.17 -30.46 60.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.48 -176.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.8 m-85 -112.53 -31.11 6.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 25.1 mt-10 -49.97 -36.9 29.99 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.446 ' HB3' ' OE1' ' A' ' 205' ' ' GLU . 49.4 ttp180 -61.2 -52.69 63.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 204' ' ' ARG . 6.1 mp0 -73.17 -28.83 62.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 178' ' ' VAL . 47.9 t -62.2 -55.74 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.88 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.0 mttt -55.46 -41.89 73.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.716 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.18 -40.5 70.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.05 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.54 -42.78 41.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 206' ' ' VAL . 82.2 mmm -58.37 -30.02 66.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.413 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 99.7 mtt180 -67.01 -19.68 65.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.173 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -102.54 -13.19 17.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.293 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.556 ' HB2' HG21 ' A' ' 188' ' ' VAL . 17.9 m0 -54.81 120.94 7.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.67 0.748 . . . . 0.0 111.96 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -96.87 140.85 30.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.725 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' A' ' 153' ' ' PRO . 30.2 t80 -130.13 147.85 51.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 154' ' ' ARG . 32.7 mt-10 -68.64 118.75 63.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.352 0.596 . . . . 0.0 111.75 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 12.2 Cg_exo -68.03 144.8 65.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.046 2.497 . . . . 0.0 111.797 -175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.24 -6.63 32.26 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.719 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.418 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 45.0 mmtm -130.71 118.81 17.93 Favored Pre-proline 0 C--O 1.221 -0.41 0 N-CA-C 110.445 -0.206 . . . . 0.0 110.445 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.44 136.79 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.321 2.014 . . . . 0.0 111.253 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -126.12 116.8 2.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.593 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -103.62 123.98 47.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.914 0.388 . . . . 0.0 110.769 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 78.26 54.39 4.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.001 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.8 mt -95.0 113.43 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.4 p -103.57 131.67 51.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.188 0.518 . . . . 0.0 110.974 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.36 147.17 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.152 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 0.2 OUTLIER -112.81 114.66 27.3 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.69 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.5 mt -103.53 119.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.732 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 229' ' ' LEU . 2.7 mm? -100.91 98.31 8.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.95 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.562 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 80.9 m-85 -87.99 84.24 6.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 231' ' ' LYS . 38.4 mmtt -65.58 147.62 53.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.544 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 19.7 tt -54.51 -20.78 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.448 -1.251 . . . . 0.0 113.143 -171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.12 -19.88 42.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.632 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.13 25.22 4.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.631 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 231' ' ' LYS . 68.2 p -106.29 167.68 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.07 0.435 . . . . 0.0 110.67 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.457 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.9 p -137.96 140.38 40.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.022 0.439 . . . . 0.0 111.392 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 31.0 tt0 -145.0 140.47 28.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.855 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 160' ' ' GLN . 1.4 mp -118.93 129.52 75.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 110.678 175.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 80.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.89 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.66 -169.05 17.8 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.866 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HB2' ' HB3' ' A' ' 215' ' ' TYR . 55.6 Cg_endo -70.75 145.79 52.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.661 2.241 . . . . 0.0 111.906 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -97.35 145.37 26.2 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.67 129.18 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.592 0.71 . . . . 0.0 112.014 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 216' ' ' GLU . 8.6 mp -98.08 -42.53 7.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.453 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.7 t -128.44 102.48 6.66 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.996 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -111.42 52.94 0.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -64.24 134.2 54.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.187 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 161' ' ' PRO . 15.7 mt-30 -83.24 134.5 45.74 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.93 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 23.6 Cg_exo -61.02 161.3 22.79 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.94 2.426 . . . . 0.0 111.867 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 6.6 tp60 -90.59 137.35 32.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 0.0 110.911 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 29.3 p90 -72.22 142.94 85.3 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.474 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 6.2 Cg_endo -92.21 125.43 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.784 2.989 . . . . 0.0 111.917 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 168' ' ' GLN . . . -67.89 -19.27 64.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.653 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 170' ' ' LEU . 39.3 ttp-105 -74.85 -37.23 62.29 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.034 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.64 -36.45 68.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 pt20 -68.4 -31.91 71.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.266 0.555 . . . . 0.0 110.524 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.49 60.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.867 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 166' ' ' ARG . 7.5 mp -91.87 2.45 56.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.872 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 60.04 37.65 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.174 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 173' ' ' GLU . 18.1 mt -97.2 155.47 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.238 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 172' ' ' ILE . 24.4 mt-10 -123.29 115.81 22.3 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -79.33 103.22 2.02 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.172 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.89 103.34 14.01 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 196' ' ' ALA . 4.9 m -112.58 127.66 69.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.247 0.546 . . . . 0.0 111.238 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HG2' HD12 ' A' ' 194' ' ' LEU . 38.9 ttpt -109.82 110.31 21.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.858 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.784 HG22 HG13 ' A' ' 193' ' ' ILE . 2.7 t -115.9 145.51 21.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.196 -172.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HB2' HD11 ' A' ' 194' ' ' LEU . 38.0 ttmt -116.3 134.37 54.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 188' ' ' VAL . 18.7 p90 -141.92 173.72 11.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.187 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 69.6 m-20 -130.52 155.05 47.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.511 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 221' ' ' GLY . 2.9 m -127.09 149.82 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.778 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 23.8 p -87.13 174.77 4.99 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-O 120.955 0.407 . . . . 0.0 111.748 -174.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.778 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 9.5 Cg_exo -65.51 -7.3 15.71 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.311 2.674 . . . . 0.0 112.114 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -108.21 -0.29 21.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.637 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.34 47.38 5.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.494 170.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.707 ' HG3' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -129.15 145.69 51.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.063 0.458 . . . . 0.0 110.786 175.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.701 HG21 ' HB2' ' A' ' 213' ' ' TRP . 19.0 t -87.27 133.46 30.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.877 -173.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -157.8 173.51 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.805 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 67.39 32.54 5.77 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.374 0.607 . . . . 0.0 109.941 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.27 117.62 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.175 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -138.46 120.11 15.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.561 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.784 HG13 HG22 ' A' ' 178' ' ' VAL . 2.3 mp -72.13 112.35 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.294 175.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.2 mt -72.22 -33.73 67.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.338 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.0 t -166.64 143.53 4.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.399 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 176' ' ' VAL . . . -143.54 161.52 38.26 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.074 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 5.6 tmtt? -63.47 -66.53 1.47 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 12.8 Cg_exo -80.31 -155.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.056 1.837 . . . . 0.0 111.515 164.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -119.98 -84.05 0.66 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -75.83 -14.57 60.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.057 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 97.1 mmm -64.24 -40.51 96.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 206' ' ' VAL . 34.1 m-85 -110.82 -32.25 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.51 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -51.42 -32.33 26.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -60.04 -52.68 64.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 111.395 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.7 -27.19 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.338 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.9 t -62.99 -55.32 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.959 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 99.3 mttt -57.0 -42.0 79.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.045 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 211' ' ' ARG . 84.9 m-20 -66.56 -28.11 68.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.66 0.267 . . . . 0.0 111.489 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.41 54.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 110.097 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 85.1 mtp -66.47 -22.07 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.26 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.1 mtp180 -70.93 -16.55 62.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -101.79 -11.68 18.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.911 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.701 ' HB2' HG21 ' A' ' 188' ' ' VAL . 42.0 m0 -59.76 138.17 57.85 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.494 0.664 . . . . 0.0 111.243 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -135.45 135.59 40.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.09 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 153' ' ' PRO . 24.8 m-85 -126.28 152.01 46.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.606 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.64 ' CG ' HD11 ' A' ' 156' ' ' LEU . 31.6 mt-10 -53.08 118.43 13.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.016 0.822 . . . . 0.0 111.982 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 15.1 Cg_endo -59.85 152.18 65.83 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.408 2.738 . . . . 0.0 112.269 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.5 -8.03 43.51 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.677 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -143.88 116.0 5.67 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.14 143.91 14.45 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.795 2.33 . . . . 0.0 111.99 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.486 ' H ' HG22 ' A' ' 182' ' ' VAL . . . -114.61 133.98 11.41 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.452 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 26.5 m -125.56 123.59 39.41 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.94 0.4 . . . . 0.0 111.385 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.09 50.43 10.6 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.172 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -90.17 117.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.0 t -101.82 125.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.421 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.8 152.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.963 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -126.41 121.4 32.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.439 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 238' ' ' ILE . 6.9 mt -106.59 125.87 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.175 0.512 . . . . 0.0 110.233 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -104.62 101.1 10.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.417 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 161' ' ' PRO . 74.7 m-85 -91.9 103.07 15.65 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.2 mmpt? -69.05 162.52 26.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.129 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.97 -31.62 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.996 0.427 . . . . 0.0 112.116 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.84 -26.61 63.36 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.257 0.551 . . . . 0.0 110.719 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.21 5.04 21.86 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.817 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 72.1 p -74.19 163.62 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.306 -0.526 . . . . 0.0 109.639 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.421 HG22 ' CD2' ' A' ' 230' ' ' PHE . 12.4 p -133.36 146.98 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -170.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 2.0 tt0 -145.88 140.83 27.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.571 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.497 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -120.55 130.85 74.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.383 179.453 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.25 -169.71 54.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.221 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.51 120.22 7.33 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.316 2.01 . . . . 0.0 111.589 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 215' ' ' TYR . 1.9 tpt180 -83.35 139.34 33.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -98.78 107.81 20.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.977 0.418 . . . . 0.0 112.015 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 216' ' ' GLU . 2.6 mm? -80.23 -41.58 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.8 t -129.72 107.63 9.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.915 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -118.16 58.58 0.82 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -65.67 152.06 45.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.839 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 236' ' ' THR . 3.5 mm100 -80.95 130.1 64.86 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.937 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.426 ' HG2' HD13 ' A' ' 228' ' ' ILE . 19.7 Cg_exo -62.5 155.18 59.64 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.517 2.144 . . . . 0.0 111.066 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -88.12 111.79 21.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.025 0.44 . . . . 0.0 111.344 -170.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 43.1 p90 -69.95 142.45 90.62 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.631 ' HB2' ' HG2' ' A' ' 166' ' ' ARG . 9.7 Cg_endo -95.19 136.34 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 112.803 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.01 -25.53 67.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.969 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.631 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 15.4 ptm180 -63.24 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.77 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 0.0 109.987 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.34 -31.67 65.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.48 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.85 -27.14 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.418 0.627 . . . . 0.0 109.838 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.8 mm? -89.99 -1.44 57.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.328 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 171' ' ' ARG . 0.2 OUTLIER 56.92 37.89 29.07 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.859 -177.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 170' ' ' LEU . 39.3 mt -91.78 151.16 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.646 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 25.0 mt-10 -121.9 117.12 25.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -77.23 101.75 1.64 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.989 -171.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 30.1 tt0 -98.83 102.3 13.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 228' ' ' ILE . 1.7 m -112.4 136.76 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.125 0.488 . . . . 0.0 110.423 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.429 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.6 ttpp -124.12 108.58 12.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 193' ' ' ILE . 3.5 t -115.57 146.29 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.83 125.05 53.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 191' ' ' VAL . 25.9 p90 -129.51 174.97 9.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.448 0.642 . . . . 0.0 110.518 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.767 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 3.0 t70 -137.1 153.26 50.59 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.416 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.6 m -131.26 147.99 32.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.853 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.5 p -82.45 177.01 3.27 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.419 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.853 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.4 Cg_exo -54.71 -36.09 89.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.13 1.887 . . . . 0.0 110.227 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 217' ' ' PRO . 10.8 m-20 -81.7 5.7 17.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.7 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.46 53.97 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.618 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 1.6 mmp_? -96.75 127.41 42.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.242 0.544 . . . . 0.0 111.023 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.5 t -79.54 117.24 24.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.455 -177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.78 174.67 12.78 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.304 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 90.7 m-20 64.75 27.79 13.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.561 0.696 . . . . 0.0 110.361 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.524 HG11 ' HG2' ' A' ' 207' ' ' LYS . 79.1 t -72.71 122.41 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.762 -177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -131.75 113.89 14.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 178' ' ' VAL . 2.4 mp -70.24 119.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.183 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.429 HD12 ' HG2' ' A' ' 177' ' ' LYS . 17.5 mt -79.21 -42.02 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.126 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 67.0 m -160.1 148.08 16.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.833 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -150.24 156.98 42.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.031 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 53.1 tptt -56.58 -64.4 2.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 4.9 Cg_endo -89.51 -159.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.391 2.061 . . . . 0.0 110.844 166.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -105.56 -104.48 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.135 -0.353 . . . . 0.0 110.949 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 203' ' ' GLU . 9.5 p30 -71.34 -10.19 59.35 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.513 0.197 . . . . 0.0 111.462 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 198' ' ' PRO . 88.8 mmm -54.77 -40.24 69.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.146 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' VAL . 38.7 m-85 -111.27 -29.55 7.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.176 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 200' ' ' ASN . 1.7 mt-10 -51.84 -37.15 50.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.787 -173.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -70.27 -44.71 67.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.902 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -26.84 52.12 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.608 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 42.2 t -59.4 -60.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.524 ' HG2' HG11 ' A' ' 191' ' ' VAL . 36.6 mtmm -58.31 -38.19 76.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.464 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -58.74 -42.24 88.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.765 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.19 -36.35 55.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.8 mtp -62.59 -31.22 72.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.158 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -64.07 -23.46 67.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -89.02 -18.82 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.488 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.783 ' HB2' HG21 ' A' ' 188' ' ' VAL . 38.8 m0 -53.9 122.02 9.19 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.441 0.639 . . . . 0.0 110.827 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' ARG . 25.6 mmt180 -109.21 120.14 41.62 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.02 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' ARG . 65.5 m-85 -112.39 142.42 44.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.166 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 156' ' ' LEU . 32.6 mt-10 -57.9 125.05 72.39 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.318 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 216' ' ' GLU . 13.5 Cg_exo -67.44 159.12 53.9 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.034 2.49 . . . . 0.0 111.739 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' PRO . . . 97.94 -2.28 59.92 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -173.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -141.51 107.95 6.07 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.97 152.04 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.08 2.52 . . . . 0.0 111.44 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.63 125.37 2.12 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t -111.87 142.17 44.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 111.005 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.08 43.79 55.98 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.474 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 mt -92.21 124.73 44.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.67 137.27 30.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.251 0.548 . . . . 0.0 111.122 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.55 152.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.535 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.3 t30 -126.42 123.23 37.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.748 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 237' ' ' GLU . 5.4 mt -111.91 116.41 52.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.728 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 236' ' ' THR . 2.6 mm? -94.04 98.92 11.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.176 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.568 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 91.0 m-85 -85.22 85.49 7.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.58 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.0 mmpt? -68.3 151.61 46.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.13 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.43 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 8.0 tt -63.8 -17.87 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.344 -173.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -70.79 -22.0 62.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.879 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 105.21 10.54 31.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.192 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 63.8 p -109.73 158.77 17.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 56.8 p -132.16 164.14 26.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.768 0.318 . . . . 0.0 110.965 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 32.3 tt0 -147.39 129.59 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.186 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 228' ' ' ILE . 2.1 mt -104.62 125.39 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 68.1 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.357 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 121.047 0.451 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.7 177.15 35.39 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.01 139.79 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.937 2.425 . . . . 0.0 111.727 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -92.8 135.94 33.68 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -90.67 129.02 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.713 0.768 . . . . 0.0 111.954 -174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD21 ' HG3' ' A' ' 216' ' ' GLU . 3.1 mm? -90.66 -37.19 13.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.495 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 213' ' ' TRP . 33.6 t -142.41 83.98 1.84 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.98 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.478 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 28.9 mtp85 -87.83 63.1 7.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.21 146.5 54.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.379 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -78.16 126.35 83.66 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.761 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.729 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.0 Cg_exo -60.52 161.12 21.62 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.515 2.144 . . . . 0.0 111.794 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.75 119.84 25.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.05 -172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 30.7 p90 -67.74 130.45 92.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 2.4 Cg_endo -83.51 139.82 9.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.299 2.666 . . . . 0.0 112.509 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' CG ' ' A' ' 168' ' ' GLN . . . -68.86 -21.85 64.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.411 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -60.87 -37.75 83.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.179 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.35 15.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.754 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.542 ' CG ' ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -63.2 -31.08 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.11 -19.97 63.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.326 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.663 ' HB3' HG13 ' A' ' 172' ' ' ILE . 1.1 mm? -103.04 5.88 38.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.291 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 58.81 33.96 23.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.759 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 170' ' ' LEU . 20.8 mt -94.62 129.16 45.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.614 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HB3' ' N ' ' A' ' 232' ' ' ILE . 0.0 OUTLIER -105.66 118.29 36.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.041 170.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 202' ' ' PHE . . . -71.48 145.42 38.88 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.625 -170.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -142.71 102.1 3.98 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.5 m -116.01 142.16 30.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.223 0.535 . . . . 0.0 111.035 -175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 194' ' ' LEU . 25.4 ttmm -121.38 110.22 15.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.668 HG21 HG11 ' A' ' 206' ' ' VAL . 3.5 t -118.69 144.87 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 0.0 111.662 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -112.81 125.25 54.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.611 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 191' ' ' VAL . 22.9 p90 -130.88 171.94 12.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.058 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.48 149.85 49.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.707 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.1 m -122.87 144.57 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 4.0 p -88.3 174.66 4.88 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.404 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 19.8 Cg_endo -60.43 -10.97 14.86 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 C-N-CA 121.978 1.786 . . . . 0.0 111.322 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.45 2.68 56.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.974 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 70.07 30.9 69.52 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.41 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 mtt180 -105.78 131.87 52.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.497 0.189 . . . . 0.0 110.941 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.3 t -80.81 123.17 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.202 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.99 172.9 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.1 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.48 34.17 20.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.421 0.629 . . . . 0.0 110.833 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 180' ' ' PHE . 85.4 t -76.25 119.71 24.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.068 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.95 126.12 31.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.656 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.4 122.87 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 177' ' ' LYS . 15.3 mt -81.71 -35.17 30.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.969 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 t -170.48 146.78 2.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.028 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.49 165.53 29.16 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.965 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 45.9 tptt -56.66 -68.26 0.64 Allowed Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.275 0.359 . . . . 0.0 110.064 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.965 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.2 Cg_endo -94.22 -164.96 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.704 2.27 . . . . 0.0 111.267 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.03 -110.61 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.455 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 204' ' ' ARG . 8.0 p30 -65.88 -11.87 50.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.609 ' HG2' ' CD1' ' A' ' 202' ' ' PHE . 47.5 ttm -52.59 -42.05 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.339 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 206' ' ' VAL . 25.9 m-85 -111.76 -32.79 6.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 13.1 mt-10 -53.14 -28.83 27.94 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.469 ' HB2' ' OE1' ' A' ' 205' ' ' GLU . 13.8 mtm180 -75.63 -47.9 24.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.507 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 204' ' ' ARG . 0.7 OUTLIER -73.7 -25.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.198 -169.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 178' ' ' VAL . 40.6 t -61.45 -60.41 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.554 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 60.1 mtpt -60.98 -34.47 74.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.439 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -58.54 -42.92 88.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.43 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -77.88 -35.53 50.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 90.2 mtp -66.07 -22.97 66.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.242 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 70.8 mtp180 -63.14 -25.39 68.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.271 0.558 . . . . 0.0 110.501 171.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -100.02 -4.8 29.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.631 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.662 ' HB2' HG21 ' A' ' 188' ' ' VAL . 21.5 m0 -64.54 129.06 38.4 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 168.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -131.52 131.45 43.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 52.2 m-85 -116.45 146.82 42.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.849 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.638 ' HG3' HD21 ' A' ' 156' ' ' LEU . 43.0 mt-10 -58.59 120.06 41.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.31 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.6 Cg_endo -57.77 152.88 46.69 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.76 -6.64 33.25 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.176 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -143.72 117.91 6.05 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -91.93 152.24 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.194 2.596 . . . . 0.0 111.899 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 118.1 1.49 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 12.9 m -108.52 126.46 52.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.863 0.363 . . . . 0.0 111.193 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 79.18 42.91 11.27 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.738 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.56 122.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.38 135.31 41.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.624 . . . . 0.0 111.026 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.98 155.44 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.819 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.521 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 1.6 t30 -125.89 117.36 23.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.704 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.729 HD13 ' HG2' ' A' ' 161' ' ' PRO . 6.8 mt -106.96 120.31 58.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.467 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 2.8 mm? -98.79 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.694 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 161' ' ' PRO . 72.1 m-85 -95.37 92.46 6.72 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 24.4 mmtp -64.91 140.53 58.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.499 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 15.8 tt -59.81 -17.27 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.558 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.459 HD22 HG23 ' A' ' 235' ' ' THR . 9.4 t30 -72.62 -21.68 61.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.913 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.99 22.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.979 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.459 HG23 HD22 ' A' ' 233' ' ' ASN . 81.3 p -84.25 161.81 20.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 1.8 p -138.49 140.43 39.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.788 0.327 . . . . 0.0 110.901 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 5.5 mt-10 -138.61 145.25 40.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.519 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 228' ' ' ILE . 1.6 mp -125.14 132.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.295 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . 49.7 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.196 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.601 0.239 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.91 -174.95 53.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.051 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.597 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 28.2 Cg_endo -69.98 149.75 65.91 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.279 1.986 . . . . 0.0 111.814 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 46.8 ttm105 -137.42 121.52 17.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.214 0.53 . . . . 0.0 109.965 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.93 109.4 22.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' A' ' 216' ' ' GLU . 0.3 OUTLIER -64.41 -44.13 92.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.368 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.0 t -122.98 92.98 3.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.454 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -109.02 71.48 0.77 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.478 0.656 . . . . 0.0 109.67 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 212' ' ' ARG . 8.0 p30 -67.95 127.79 34.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.573 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 160' ' ' GLN . 10.4 mt-30 -73.11 129.81 85.71 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.264 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 230' ' ' PHE . 22.6 Cg_exo -60.07 161.28 19.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.968 2.445 . . . . 0.0 111.636 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.72 124.16 35.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 0.0 111.361 -172.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 3.4 p90 -68.75 131.42 91.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.222 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 1.9 Cg_endo -85.43 137.35 5.9 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.318 2.678 . . . . 0.0 112.126 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.869 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -61.43 -48.05 82.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 109.892 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 172' ' ' ILE . . . -68.2 -33.34 74.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.894 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.03 -39.42 94.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.45 63.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.611 . . . . 0.0 110.068 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.574 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.1 mm? -86.37 -1.0 57.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.904 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.454 ' HB3' HD11 ' A' ' 232' ' ' ILE . 29.9 mmt180 59.13 38.63 23.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.809 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 170' ' ' LEU . 15.5 mt -91.13 126.84 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.844 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.725 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 23.9 mt-10 -89.86 121.37 31.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -88.42 98.18 2.39 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.694 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 14.0 tt0 -97.37 102.89 14.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 206' ' ' VAL . 3.4 m -117.93 124.84 73.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.62 0.724 . . . . 0.0 111.537 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -103.01 117.4 34.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.446 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.749 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -125.98 143.35 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 111.969 -170.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -111.56 140.81 45.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.538 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.426 ' HB3' HG22 ' A' ' 191' ' ' VAL . 17.2 p90 -143.01 172.1 13.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.664 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 0.3 OUTLIER -137.85 143.41 40.93 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.399 177.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.5 m -123.59 147.38 27.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.117 0.484 . . . . 0.0 109.724 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 25.6 p -86.44 165.28 34.06 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.669 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 31.3 Cg_endo -63.82 -6.82 11.61 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.994 2.462 . . . . 0.0 112.474 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -107.13 -0.9 22.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.38 0.609 . . . . 0.0 110.2 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.42 46.79 4.24 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.482 -0.781 . . . . 0.0 114.043 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 27.6 mmt180 -114.69 141.2 48.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.081 0.44 . . . . 0.0 110.307 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 213' ' ' TRP . 15.3 t -89.08 124.27 41.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.917 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.08 173.39 14.41 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 69.4 m-80 62.63 32.13 16.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.521 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 180' ' ' PHE . 98.9 t -79.21 118.73 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.585 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -143.58 130.89 20.88 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.55 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.749 HG13 HG22 ' A' ' 178' ' ' VAL . 3.0 mp -87.11 120.53 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.496 0.665 . . . . 0.0 110.405 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -84.71 -32.73 23.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.232 -175.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -155.11 145.41 21.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.441 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 175' ' ' GLN . . . -149.44 158.31 44.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.936 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 1.9 tmtp? -61.71 -57.06 26.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 2.0 Cg_endo -89.94 -155.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.567 2.178 . . . . 0.0 109.935 165.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.83 -92.11 0.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.521 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -92.63 -1.44 56.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.763 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 94.7 mmm -58.26 -40.7 82.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.553 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.645 ' O ' HG23 ' A' ' 206' ' ' VAL . 28.5 m-85 -110.82 -33.71 6.45 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.712 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.485 ' HG2' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -53.43 -34.39 57.64 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.665 0.603 . . . . 0.0 110.875 -176.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -61.12 -48.12 83.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.005 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -24.06 40.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.401 . . . . 0.0 110.307 -174.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 202' ' ' PHE . 61.8 t -64.05 -54.12 35.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.323 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 27.1 mttp -54.08 -42.37 69.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.459 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 0.2 OUTLIER -61.73 -44.09 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.614 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.12 74.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 82.0 mmm -58.97 -35.37 73.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.532 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 53.1 mtp180 -66.58 -19.38 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 110.82 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 208' ' ' ASN . 45.2 mtt180 -94.68 -16.74 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.99 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.709 ' HB2' HG21 ' A' ' 188' ' ' VAL . 22.4 m0 -52.15 136.52 29.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.342 0.592 . . . . 0.0 112.088 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 0.1 OUTLIER -111.01 127.67 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.07 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.607 ' HE1' ' HB2' ' A' ' 219' ' ' LYS . 39.5 t80 -114.33 151.78 32.45 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.359 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.475 ' CG ' HD23 ' A' ' 156' ' ' LEU . 53.6 mt-10 -63.51 119.28 52.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.413 0.446 . . . . 0.0 112.079 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 24.3 Cg_endo -62.07 139.65 79.85 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.69 2.26 . . . . 0.0 111.798 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.09 -6.62 32.52 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.187 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.607 ' HB2' ' HE1' ' A' ' 215' ' ' TYR . 31.9 mmtp -134.83 124.55 16.78 Favored Pre-proline 0 C--O 1.223 -0.313 0 CA-C-N 116.743 0.272 . . . . 0.0 111.152 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -99.13 146.75 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.876 2.384 . . . . 0.0 111.988 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.7 116.03 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.435 ' HB3' ' OD2' ' A' ' 181' ' ' ASP . 4.1 p -113.15 136.71 52.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.827 0.346 . . . . 0.0 111.613 -177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.85 37.83 11.17 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.35 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.61 118.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.43 130.53 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.402 0.62 . . . . 0.0 111.385 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.37 160.16 42.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.597 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -126.83 130.05 49.48 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.492 ' N ' HD22 ' A' ' 227' ' ' ASN . 7.9 mt -112.72 122.28 66.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mt -109.52 97.87 7.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.068 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 236' ' ' THR . 78.6 m-85 -87.48 86.77 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 9.8 mmpt? -64.7 147.76 52.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.26 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.725 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 13.7 tt -52.96 -24.65 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.67 -168.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.425 HD22 ' H ' ' A' ' 233' ' ' ASN . 0.1 OUTLIER -76.95 -8.98 58.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.71 35.05 4.74 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.316 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 61.1 p -114.06 169.63 8.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.85 0.357 . . . . 0.0 110.535 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 230' ' ' PHE . 40.1 p -136.1 140.21 43.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.694 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -151.46 131.49 13.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.319 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 228' ' ' ILE . 1.4 mp -105.59 131.8 54.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.508 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.413 -175.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.23 47.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.235 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.39 104.49 0.43 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.882 2.388 . . . . 0.0 111.846 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -99.06 130.69 45.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 158' ' ' ARG . . . -84.49 128.62 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.368 -175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.727 HD11 ' HG3' ' A' ' 216' ' ' GLU . 6.2 mp -87.2 -44.88 11.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.204 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.2 t -146.36 84.54 1.63 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.931 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' A' ' 155' ' ' ALA . 63.7 mtm180 -85.06 80.56 9.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 167.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 212' ' ' ARG . 8.4 p30 -78.26 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.865 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.11 128.64 80.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.568 -174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 209' ' ' ALA . 23.8 Cg_exo -60.82 154.14 57.89 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.658 2.239 . . . . 0.0 111.397 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.25 102.86 12.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 15.0 p90 -60.75 128.37 88.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.654 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.9 Cg_exo -81.93 140.7 11.54 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.353 2.702 . . . . 0.0 111.923 -173.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.67 63.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.842 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -59.32 -40.64 86.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.572 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.16 33.46 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -62.28 -40.97 98.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.553 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.671 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.703 ' HB3' HG13 ' A' ' 172' ' ' ILE . 2.0 mm? -94.09 2.78 55.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.691 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 59.83 37.12 21.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.406 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 170' ' ' LEU . 13.7 mt -104.24 132.3 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.044 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.04 129.43 46.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 167.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.61 143.93 21.06 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -145.33 104.59 3.95 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.15 0.5 . . . . 0.0 110.311 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' A' ' 196' ' ' ALA . 15.9 m -112.11 133.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.634 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -108.96 107.45 17.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 206' ' ' VAL . 5.7 t -116.02 147.01 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.251 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HB2' HD11 ' A' ' 194' ' ' LEU . 34.7 ttmt -114.25 132.55 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.88 173.48 11.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.085 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -128.25 154.55 45.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.7 m -124.2 148.85 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 21.0 p -88.21 169.4 13.83 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.311 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.7 Cg_endo -67.32 8.36 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.507 2.138 . . . . 0.0 111.185 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 183' ' ' THR . 4.7 m-20 -106.59 -9.24 16.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.6 31.0 28.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.943 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.4 mmt180 -110.27 138.13 47.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.13 0.49 . . . . 0.0 110.604 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -83.35 133.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.587 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.4 165.31 36.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.86 34.71 11.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.047 0.539 . . . . 0.0 111.372 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.62 112.31 9.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.573 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -130.73 124.24 31.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.848 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 178' ' ' VAL . 2.6 mp -72.08 114.78 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.135 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 179' ' ' LYS . 15.6 mt -78.9 -36.11 42.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.113 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 t -165.81 155.52 12.36 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -158.58 -176.68 6.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.701 0.762 . . . . 0.0 112.223 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.033 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.07 -174.11 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.638 166.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 60.8 Cg_exo -24.0 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.931 3.087 . . . . 0.0 114.355 -161.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -141.14 -104.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.194 -0.316 . . . . 0.0 111.214 167.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.61 -0.2 57.34 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.463 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 84.5 mtp -51.99 -28.92 18.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.876 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 18.8 m-85 -112.63 -12.4 13.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.45 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 12.5 mt-10 -62.64 -21.1 65.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -170.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.73 -41.76 14.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.266 0.555 . . . . 0.0 110.359 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -75.08 -29.24 60.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.265 -172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 178' ' ' VAL . 37.5 t -59.37 -57.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.158 175.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 62.0 mttp -51.69 -41.7 61.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.125 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.64 -47.21 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.391 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.691 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -74.86 -36.64 62.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 110.985 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 206' ' ' VAL . 88.5 mtp -67.02 -20.9 65.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.205 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 98.9 mtt180 -67.25 -18.27 65.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.155 0.503 . . . . 0.0 110.449 172.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 159' ' ' ASN . 81.6 mtt180 -106.73 -9.53 16.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.89 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.745 ' HB2' HG21 ' A' ' 188' ' ' VAL . 29.1 m0 -56.25 123.44 14.57 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.37 0.605 . . . . 0.0 111.39 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -105.16 127.68 53.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.732 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.26 143.04 50.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.648 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.727 ' HG3' HD11 ' A' ' 156' ' ' LEU . 42.2 mt-10 -53.02 119.93 18.01 Favored Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.431 0.457 . . . . 0.0 111.762 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 18.3 Cg_endo -59.77 145.64 97.66 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.047 2.498 . . . . 0.0 111.875 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.47 -6.78 49.9 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.654 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -123.53 104.09 34.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 184' ' ' PRO . 94.0 Cg_endo -89.97 140.94 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.872 2.381 . . . . 0.0 112.096 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -139.13 129.43 4.42 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.589 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.2 p -116.22 129.47 56.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.009 0.433 . . . . 0.0 111.22 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.21 52.18 3.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.138 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.77 118.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.58 133.07 44.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.396 0.617 . . . . 0.0 111.002 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.26 161.64 39.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.407 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -136.91 116.55 12.94 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 161' ' ' PRO . 8.0 mt -101.09 118.11 47.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.488 HD21 HE21 ' A' ' 239' ' ' GLN . 2.2 mm? -98.7 99.28 10.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.915 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.571 ' HA ' HG22 ' A' ' 236' ' ' THR . 51.4 m-85 -89.58 83.37 6.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 11.8 mmpt? -68.38 145.33 54.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.351 0.596 . . . . 0.0 110.551 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.32 -15.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.756 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -70.58 -21.94 62.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.592 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 114.66 7.04 18.69 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.803 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 76.1 p -106.72 160.51 15.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.055 0.427 . . . . 0.0 109.916 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 230' ' ' PHE . 19.3 p -136.43 162.08 34.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.068 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.2 tt0 -152.53 131.69 12.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.519 -175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 228' ' ' ILE . 1.3 mp -112.69 123.99 68.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.115 0.483 . . . . 0.0 110.315 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.488 HE21 HD21 ' A' ' 229' ' ' LEU . 58.7 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.506 0.193 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.05 174.73 31.78 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.227 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.427 ' HG3' HG21 ' A' ' 182' ' ' VAL . 74.0 Cg_endo -79.15 146.39 19.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.887 2.391 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 154' ' ' ARG . 0.8 OUTLIER -98.78 161.95 13.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.29 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -105.41 107.95 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.6 -43.59 69.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.107 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 214' ' ' ARG . 30.5 t -159.51 110.58 2.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.841 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -99.09 82.77 2.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.307 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -66.98 129.54 40.22 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.504 0.668 . . . . 0.0 111.336 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 160' ' ' GLN . 1.7 mm100 -75.58 127.69 85.42 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.027 176.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.475 ' HG2' HD13 ' A' ' 228' ' ' ILE . 21.5 Cg_exo -61.03 153.49 63.76 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.383 2.055 . . . . 0.0 111.238 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -74.57 140.95 44.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.718 ' CE1' ' HB3' ' A' ' 230' ' ' PHE . 2.7 t80 -72.33 142.77 84.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 9.8 Cg_endo -89.29 128.14 1.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 124.136 3.224 . . . . 0.0 112.525 -173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.75 70.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.242 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.577 ' HB2' ' SD ' ' A' ' 201' ' ' MET . 74.1 mtp180 -65.45 -45.98 81.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.709 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 201' ' ' MET . . . -70.87 -30.72 67.18 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.595 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -61.9 -36.52 81.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.59 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.74 68.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.91 -2.44 50.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.068 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 58.28 40.36 24.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.266 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 167' ' ' ALA . 39.5 mt -91.71 154.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.06 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 172' ' ' ILE . 20.7 mt-10 -114.13 133.81 55.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -109.71 117.93 4.97 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.994 -174.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.52 102.96 11.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.469 0.652 . . . . 0.0 109.465 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.732 HG22 ' HB ' ' A' ' 228' ' ' ILE . 2.6 m -103.07 139.01 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 194' ' ' LEU . 26.2 ttpp -118.61 109.33 16.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 193' ' ' ILE . 2.8 t -115.21 145.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.642 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -109.8 130.85 55.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.561 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -136.64 173.55 11.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.303 0.573 . . . . 0.0 110.402 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 222' ' ' SER . 15.1 m-20 -131.39 153.63 49.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.232 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 2.9 m -126.28 151.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.837 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 33.0 p -93.1 177.06 2.17 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 120.913 0.387 . . . . 0.0 111.517 -176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.837 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 13.6 Cg_exo -63.27 -7.77 12.91 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.064 2.51 . . . . 0.0 111.348 173.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 -4.81 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.151 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.57 27.33 54.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.473 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 34.8 mmt180 -96.6 128.76 43.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.031 0.443 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.8 t -79.34 125.64 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -149.5 165.38 32.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.141 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.49 32.26 7.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.326 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 93.7 t -74.53 115.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.41 121.61 24.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.211 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.561 HG13 HG22 ' A' ' 178' ' ' VAL . 2.8 mp -75.36 118.53 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 177' ' ' LYS . 16.4 mt -77.94 -37.71 47.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.142 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.8 t -170.6 139.32 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 176' ' ' VAL . . . -137.43 166.79 23.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.215 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.028 ' HB3' ' HD3' ' A' ' 198' ' ' PRO . 23.8 tptm -58.79 -64.23 3.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 197' ' ' LYS . 11.7 Cg_endo -99.29 145.29 0.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.107 1.872 . . . . 0.0 111.894 161.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.25 -74.79 0.15 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.118 -0.947 . . . . 0.0 112.345 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -71.8 4.46 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 166' ' ' ARG . 42.0 tpp -89.92 -53.89 4.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 206' ' ' VAL . 30.7 m-85 -101.79 -29.7 11.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 193' ' ' ILE . 22.3 mt-10 -49.69 -37.37 28.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.653 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -29.11 32.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.488 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 202' ' ' PHE . 58.3 t -60.87 -55.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.007 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 28.9 mtpp -57.0 -39.86 75.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.201 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -62.0 -42.52 99.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.782 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -76.89 -39.9 49.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 83.3 mtp -65.99 -27.0 67.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 73.7 mtp180 -63.19 -24.05 67.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.366 0.603 . . . . 0.0 110.627 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -104.05 -3.64 24.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.736 ' HB2' HG21 ' A' ' 188' ' ' VAL . 19.6 m0 -54.15 138.77 37.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.139 0.495 . . . . 0.0 111.262 174.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 157' ' ' SER . 22.1 mmt180 -115.91 123.04 47.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.351 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.61 157.01 38.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.308 174.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.05 138.28 94.88 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.473 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.29 157.96 19.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 112.306 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.12 35.65 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.158 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -147.93 113.11 3.91 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.18 152.35 16.15 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.849 2.366 . . . . 0.0 111.89 171.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -133.25 133.45 6.99 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 181' ' ' ASP . 3.3 m -113.4 132.28 55.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.738 0.269 . . . . 0.0 111.181 -174.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 62.62 55.48 26.95 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.13 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.25 127.91 49.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.08 140.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.023 0.44 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 m -138.12 160.07 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.024 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -120.85 119.76 33.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.419 177.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 176' ' ' VAL . 8.3 mt -105.01 112.57 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 0.0 109.892 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.708 ' HB3' ' HE3' ' A' ' 231' ' ' LYS . 3.1 mm? -96.94 99.56 11.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.04 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.718 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 88.9 m-85 -87.42 106.05 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.708 ' HE3' ' HB3' ' A' ' 229' ' ' LEU . 11.9 mmpt? -87.6 150.38 23.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.427 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 12.3 tt -59.92 -17.84 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.774 0.671 . . . . 0.0 111.997 -173.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -70.43 -17.27 63.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.99 -0.03 54.99 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.731 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 68.9 p -87.27 161.31 18.05 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.988 0.423 . . . . 0.0 109.956 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 230' ' ' PHE . 43.3 p -134.15 147.63 50.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 -172.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 33.8 tt0 -141.41 140.14 33.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 228' ' ' ILE . 1.9 mp -122.79 125.9 73.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.139 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.233 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.676 0.275 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.75 -174.4 51.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.961 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.41 132.7 52.39 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.731 2.288 . . . . 0.0 111.483 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.954 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -88.12 132.02 34.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 -176.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.49 107.74 13.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.222 0.534 . . . . 0.0 110.695 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 216' ' ' GLU . 18.5 tp -72.43 -34.86 68.13 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.763 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 t -157.74 97.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.017 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -109.72 68.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -70.73 153.51 42.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.223 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.577 ' HA ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -82.1 133.35 51.27 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.978 -177.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.49 ' HG2' HD13 ' A' ' 228' ' ' ILE . 24.5 Cg_exo -60.3 157.24 36.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.725 2.283 . . . . 0.0 111.963 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -76.82 113.19 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.321 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.516 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 10.3 p90 -74.1 134.76 77.23 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.007 173.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.1 Cg_endo -88.33 137.12 3.56 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.597 2.865 . . . . 0.0 111.85 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.57 -23.63 66.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -59.86 -43.39 94.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.177 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.459 ' HB2' ' HE2' ' A' ' 201' ' ' MET . . . -71.72 -35.66 70.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -63.34 -40.38 97.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.515 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.48 -19.64 62.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 172' ' ' ILE . 3.3 mm? -95.34 2.43 54.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 63.82 25.37 14.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.129 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 170' ' ' LEU . 29.7 mt -91.72 154.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.902 0.382 . . . . 0.0 110.696 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.479 ' HG2' ' HB ' ' A' ' 232' ' ' ILE . 19.8 mt-10 -123.39 121.7 36.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.444 ' O ' ' HD1' ' A' ' 230' ' ' PHE . . . -80.95 120.21 5.07 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.44 -175.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -121.01 103.74 9.27 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.308 -0.525 . . . . 0.0 109.64 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 228' ' ' ILE . 3.0 m -108.38 147.67 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.538 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 177' ' ' LYS . 5.0 ttmp? -130.14 113.79 14.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 206' ' ' VAL . 2.8 t -124.72 147.36 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.673 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 194' ' ' LEU . 4.1 ttmp? -114.11 134.14 55.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 170.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.505 ' HB3' HG22 ' A' ' 191' ' ' VAL . 27.1 p90 -141.68 173.73 11.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -132.98 143.22 49.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 1.6 m -119.96 146.2 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 184' ' ' PRO . 19.2 p -86.53 168.11 19.98 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 183' ' ' THR . 37.6 Cg_endo -67.63 7.98 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.477 2.118 . . . . 0.0 111.689 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -104.22 -9.77 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.28 0.562 . . . . 0.0 109.889 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 215' ' ' TYR . . . 86.66 39.47 7.64 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.239 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 18.1 mmm180 -119.62 133.96 55.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.272 0.558 . . . . 0.0 111.673 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 213' ' ' TRP . 21.6 t -83.78 131.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.92 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -155.94 172.12 18.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 60.36 38.35 19.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.473 0.654 . . . . 0.0 110.598 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 180' ' ' PHE . 74.7 t -81.34 119.07 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.719 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -127.33 121.88 32.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.04 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 178' ' ' VAL . 2.2 mp -72.84 113.65 10.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.412 0.625 . . . . 0.0 109.838 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 179' ' ' LYS . 17.4 mt -75.13 -36.67 61.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.029 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -172.07 162.41 5.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . . . -158.64 -173.85 4.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.0 111.858 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 1.081 ' HB2' ' HD2' ' A' ' 198' ' ' PRO . 0.0 OUTLIER -58.75 -174.61 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.935 167.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 1.081 ' HD2' ' HB2' ' A' ' 197' ' ' LYS . 91.0 Cg_exo -25.98 -78.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.792 2.995 . . . . 0.0 114.658 -163.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.517 ' N ' ' HZ3' ' A' ' 197' ' ' LYS . . . -142.05 -106.72 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.164 -0.335 . . . . 0.0 111.598 170.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -84.08 -6.02 59.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.58 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 78.6 mtp -51.46 -35.83 41.51 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -174.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 39.2 m-85 -113.82 -21.57 10.6 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' A' ' 193' ' ' ILE . 8.2 tm-20 -64.26 -20.69 66.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.795 0.331 . . . . 0.0 111.85 -167.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -76.49 -51.05 12.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.312 0.577 . . . . 0.0 110.449 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.521 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 202' ' ' PHE . 48.3 t -61.73 -58.01 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.876 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 211' ' ' ARG . 57.7 mtmt -58.21 -40.18 80.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.432 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -58.97 -36.42 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . . . -80.09 -39.29 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.666 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 206' ' ' VAL . 93.2 mtp -62.71 -30.66 71.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.342 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 207' ' ' LYS . 78.9 mtt180 -67.04 -20.0 65.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -96.2 -13.28 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . 0.731 ' HB2' HG21 ' A' ' 188' ' ' VAL . 35.6 m0 -57.0 126.83 28.94 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.439 0.638 . . . . 0.0 111.163 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.35 132.35 56.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.562 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 186' ' ' GLY . 71.4 m-85 -114.92 149.36 37.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.571 ' HG2' HD13 ' A' ' 156' ' ' LEU . 53.6 mt-10 -60.53 115.33 13.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 123.544 0.527 . . . . 0.0 110.67 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 216' ' ' GLU . 11.0 Cg_endo -54.76 147.86 48.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.577 2.851 . . . . 0.0 112.79 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.09 35.9 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.725 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -135.75 108.79 10.0 Favored Pre-proline 0 C--O 1.228 -0.066 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -87.21 152.28 8.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.127 2.551 . . . . 0.0 111.638 171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -147.61 130.48 3.54 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.6 t -120.0 145.02 47.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.377 0.589 . . . . 0.0 111.202 -173.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 71.02 40.45 62.27 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.336 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 179' ' ' LYS . 2.9 mt -89.86 117.55 33.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.74 133.51 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.191 0.519 . . . . 0.0 110.486 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 2.4 m -130.78 155.13 41.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.044 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 239' ' ' GLN . 2.7 t30 -130.14 122.04 27.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.791 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.699 HG23 HG13 ' A' ' 238' ' ' ILE . 7.9 mt -106.54 123.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.278 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.45 99.48 9.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.348 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 174' ' ' GLY . 67.0 m-85 -89.76 88.69 7.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.693 ' HA ' ' HE2' ' A' ' 231' ' ' LYS . 10.9 mmpt? -71.4 154.97 41.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -172.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HB ' ' HG2' ' A' ' 173' ' ' GLU . 16.1 tt -59.04 -22.39 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.323 -176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -21.74 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.136 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.9 7.29 41.75 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.9 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 70.2 p -95.31 158.07 15.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.0 p -141.56 145.22 34.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.569 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -155.06 139.21 16.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.699 HG13 HG23 ' A' ' 228' ' ' ILE . 3.3 mp -105.64 136.54 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.603 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 226' ' ' VAL . 69.3 mt-30 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.9 175.283 . . . . . . . . 1 1 . 1 stop_ save_